Protein	B-protein
kinase	I-protein
C-zeta	I-protein
mediates	O
NF-kappa	B-protein
B	I-protein
activation	O
in	O
human	B-cell_type
immunodeficiency	I-cell_type
virus-infected	I-cell_type
monocytes	I-cell_type
.	O

The	O
molecular	O
mechanisms	O
regulating	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)	O
persistence	O
in	O
a	O
major	O
cell	O
reservoir	O
such	O
as	O
the	O
macrophage	B-cell_type
remain	O
unknown	O
.	O

NF-kappa	B-protein
B	I-protein
is	O
a	O
transcription	B-protein
factor	I-protein
involved	O
in	O
the	O
regulation	O
of	O
the	O
HIV	B-DNA
long	I-DNA
terminal	I-DNA
repeat	I-DNA
and	O
is	O
selectively	O
activated	O
following	O
HIV	O
infection	O
of	O
human	B-cell_type
macrophages	I-cell_type
.	O

Although	O
little	O
information	O
as	O
to	O
what	O
signal	O
transduction	O
pathways	O
mediate	O
NF-kappa	B-protein
B	I-protein
activation	O
in	O
monocytes-macrophages	B-cell_type
is	O
available	O
,	O
our	O
previous	O
work	O
indicated	O
that	O
classical	O
protein	B-protein
kinase	I-protein
C	I-protein
(	I-protein
PKC	I-protein
)	I-protein
isoenzymes	I-protein
were	O
not	O
involved	O
in	O
the	O
HIV-mediated	O
NF-kappa	B-protein
B	I-protein
activation	O
.	O

In	O
this	O
study	O
,	O
we	O
have	O
focused	O
on	O
atypical	O
PKC	B-protein
isoenzymes	I-protein
.	O

PKC-zeta	B-protein
belongs	O
to	O
this	O
family	O
and	O
is	O
known	O
to	O
be	O
an	O
important	O
step	O
in	O
NF-kappa	B-protein
B	I-protein
activation	O
in	O
other	O
cell	O
systems	O
.	O

Immunoblotting	O
experiments	O
with	O
U937	B-cell_line
cells	I-cell_line
demonstrate	O
that	O
PKC-zeta	B-protein
is	O
present	O
in	O
these	O
cells	O
,	O
and	O
its	O
expression	O
can	O
be	O
downmodulated	O
by	O
antisense	O
oligonucleotides	O
(	O
AO	O
)	O
.	O

The	O
HIV-mediated	O
NF-kappa	B-protein
B	I-protein
activation	O
is	O
selectively	O
reduced	O
by	O
AO	O
to	O
PKC-zeta	B-protein
.	O

In	O
addition	O
,	O
cotransfection	O
of	O
a	O
negative	O
dominant	O
molecule	O
of	O
PKC-zeta	B-protein
(	O
PKC-zeta	B-protein
mut	I-protein
)	O
with	O
NF-kappa	B-protein
B	I-protein
-dependent	O
reporter	O
genes	O
selectively	O
inhibits	O
the	O
HIV	O
-but	O
not	O
phorbol	O
myristate	O
acetate-	O
or	O
lipopolysaccharide-mediated	O
activation	O
of	O
NF-kappa	B-protein
B	I-protein
.	O

That	O
PKC-zeta	B-protein
is	O
specific	O
in	O
regulating	O
NF-kappa	B-protein
B	I-protein
is	O
concluded	O
from	O
the	O
inability	O
of	O
PKC-zeta	B-protein
(	I-protein
mut	I-protein
)	I-protein
to	O
interfere	O
with	O
the	O
basal	O
or	O
phorbol	O
myristate	O
acetate-inducible	O
CREB	B-protein
-or	O
AP1	B-protein
-dependent	O
transcriptional	O
activity	O
.	O

Lastly	O
,	O
we	O
demonstrate	O
a	O
selective	O
inhibition	O
of	O
p24	B-protein
production	O
by	O
HIV-infected	B-cell_type
human	I-cell_type
macrophages	I-cell_type
when	O
treated	O
with	O
AO	O
to	O
PKC-zeta	B-protein
.	O

Altogether	O
,	O
these	O
results	O
suggest	O
that	O
atypical	B-protein
PKC	I-protein
isoenzymes	I-protein
,	O
including	O
PKC-zeta	B-protein
,	O
participate	O
in	O
the	O
signal	O
transduction	O
pathways	O
by	O
which	O
HIV	O
infection	O
results	O
in	O
the	O
activation	O
of	O
NF-kappa	B-protein
B	I-protein
in	O
human	B-cell_type
monocytic	I-cell_type
cells	I-cell_type
and	O
macrophages	B-cell_type
.	O

JOURNAL	NULL
or	NULL
ViROLOGY	NULL
,	NULL
Jan.	NULL
1996	NULL
,	NULL
p.	NULL
223-231	NULL
0022-538	NULL
X	NULL
,	NULL
/96/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1996	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

70	NULL
,	NULL
No	NULL
.	NULL

1	NULL
Protein	NULL
Kinase	NULL
C-	NULL
{	NULL
Mediates	NULL
NF-KB	NULL
Activation	NULL
in	NULL
Human	NULL
Immunodeficiency	NULL
Virus-Infected	NULL
Monocytes	NULL
LOLA	NULL
FOLGUEIRA	NULL
,	NULL
'	NULL
JULIE	NULL
A.	NULL
McELHINNY	NULL
,	NULL
``	NULL
GARY	NULL
D.	NULL
BREN	NULL
,	NULL
WILLIAM	NULL
S.	NULL
MacMORRAN	NULL
,	NULL
``	NULL
MARIA	NULL
T.	NULL
DIAZ-MECO	NULL
,	NULL
``	NULL
JORGE	NULL
MOSCAT	NULL
,	NULL
``	NULL
anp	NULL
CARLOS	NULL
V.	NULL
PAYA****	NULL
Department	NULL
of	NULL
Immunology	NULL
``	NULL
and	NULL
Divisions	NULL
of	NULL
Infectious	NULL
and	NULL
Experimental	NULL
Pathology	NULL
,	NULL
``	NULL
Mayo	NULL
Clinic	NULL
,	NULL
Rochester	NULL
,	NULL
Minnesota	NULL
55905	NULL
,	NULL
and	NULL
Centro	NULL
de	NULL
Biologia	NULL
Molecular	NULL
,	NULL
Consejo	NULL
Superior	NULL
de	NULL
Investigaciones	NULL
Cientificas-UAM	NULL
,	NULL
Canto	NULL
Blanco	NULL
,	NULL
28049	NULL
Madrid	NULL
,	NULL
Spain	NULL
``	NULL
Received	NULL
9	NULL
June	NULL
1995/Accepted	NULL
17	NULL
October	NULL
1995	NULL
The	NULL
molecular	NULL
mechanisms	NULL
regulating	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
persistence	NULL
in	NULL
a	NULL
major	NULL
cell	NULL
reservoir	NULL
such	NULL
as	NULL
the	NULL
macrophage	NULL
remain	NULL
unknown	NULL
.	NULL

NF-KB	NULL
is	NULL
a	NULL
transcription	NULL
factor	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
HIV	NULL
long	NULL
terminal	NULL
repeat	NULL
and	NULL
is	NULL
selectively	NULL
activated	NULL
following	NULL
HIV	NULL
infection	NULL
of	NULL
human	NULL
macrophages	NULL
.	NULL

Although	NULL
little	NULL
information	NULL
as	NULL
to	NULL
what	NULL
signal	NULL
transduction	NULL
pathways	NULL
mediate	NULL
NF-KB	NULL
activation	NULL
in	NULL
monocytes-macrophages	NULL
is	NULL
available	NULL
,	NULL
our	NULL
previous	NULL
work	NULL
indicated	NULL
that	NULL
classical	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
isoenzymes	NULL
were	NULL
not	NULL
involved	NULL
in	NULL
the	NULL
HIV-mediated	NULL
NF-KB	NULL
activation	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
focused	NULL
on	NULL
atypical	NULL
PKC	NULL
isoenzymes	NULL
.	NULL

PKC-£	NULL
belongs	NULL
to	NULL
this	NULL
family	NULL
and	NULL
is	NULL
known	NULL
to	NULL
be	NULL
an	NULL
important	NULL
step	NULL
in	NULL
NF-B	NULL
activation	NULL
in	NULL
other	NULL
cell	NULL
systems	NULL
.	NULL

Immunoblotting	NULL
experiments	NULL
with	NULL
U937	NULL
cells	NULL
demonstrate	NULL
that	NULL
PKC-£	NULL
is	NULL
present	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
and	NULL
its	NULL
expression	NULL
can	NULL
be	NULL
downmodulated	NULL
by	NULL
antisense	NULL
oligonucleotides	NULL
(	NULL
A0	NULL
)	NULL
.	NULL

The	NULL
HIV-mediated	NULL
NF-KB	NULL
activation	NULL
is	NULL
selectively	NULL
reduced	NULL
by	NULL
AO	NULL
to	NULL
PKC-£	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
cotransfection	NULL
of	NULL
a	NULL
negative	NULL
dominant	NULL
molecule	NULL
of	NULL
PKC-£	NULL
with	NULL
NF-B-dependent	NULL
reporter	NULL
genes	NULL
selectively	NULL
inhibits	NULL
the	NULL
HIV-	NULL
but	NULL
not	NULL
phorbol	NULL
myristate	NULL
acetate-	NULL
or	NULL
lipopolysaccharide-mediated	NULL
activation	NULL
of	NULL
NF-KB	NULL
.	NULL

That	NULL
PKC-£	NULL
is	NULL
specific	NULL
in	NULL
regulating	NULL
NF-KB	NULL
is	NULL
concluded	NULL
from	NULL
the	NULL
inability	NULL
of	NULL
PKC-C	NULL
``	NULL
``	NULL
*	NULL
to	NULL
interfere	NULL
with	NULL
the	NULL
basal	NULL
or	NULL
phorbol	NULL
myristate	NULL
acetate-inducible	NULL
CREB-	NULL
or	NULL
AP1-dependent	NULL
transcriptional	NULL
activity	NULL
.	NULL

Lastly	NULL
,	NULL
we	NULL
demonstrate	NULL
a	NULL
selective	NULL
inhibition	NULL
of	NULL
p24	NULL
production	NULL
by	NULL
HIV-infected	NULL
human	NULL
macrophages	NULL
when	NULL
treated	NULL
with	NULL
AO	NULL
to	NULL
PKC-£	NULL
.	NULL

Altogether	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
atypical	NULL
PKC	NULL
isoenzymes	NULL
,	NULL
including	NULL
PKC-	NULL
,	NULL
participate	NULL
in	NULL
the	NULL
signal	NULL
transduction	NULL
pathways	NULL
by	NULL
which	NULL
HIV	NULL
infection	NULL
results	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
NF-KB	NULL
in	NULL
human	NULL
monocytic	NULL
cells	NULL
and	NULL
macrophages	NULL
.	NULL

Persistent	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
infection	NULL
of	NULL
monocytic	NULL
cell	NULL
lines	NULL
and	NULL
of	NULL
human	NULL
macrophages	NULL
results	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-kB	NULL
(	NULL
2	NULL
,	NULL
38	NULL
,	NULL
46	NULL
,	NULL
51	NULL
,	NULL
56	NULL
)	NULL
.	NULL

Macrophages	NULL
are	NULL
considered	NULL
to	NULL
be	NULL
a	NULL
major	NULL
reservoir	NULL
of	NULL
persistent	NULL
HIV	NULL
replication	NULL
in	NULL
infected	NULL
individuals	NULL
(	NULL
19	NULL
,	NULL
20	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
host	NULL
cell-virus	NULL
interaction	NULL
that	NULL
regulates	NULL
viral	NULL
replication	NULL
in	NULL
these	NULL
cells	NULL
remains	NULL
poorly	NULL
understood	NULL
.	NULL

Indirect	NULL
evidence	NULL
suggests	NULL
that	NULL
virus-induced	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
functionally	NULL
important	NULL
.	NULL

The	NULL
HIV	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
is	NULL
regulated	NULL
by	NULL
NF-KB	NULL
alone	NULL
(	NULL
41	NULL
)	NULL
and	NULL
in	NULL
collaboration	NULL
with	NULL
other	NULL
relevant	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
SP1	NULL
(	NULL
27	NULL
,	NULL
47	NULL
)	NULL
.	NULL

HIV	NULL
provi-rus	NULL
deficient	NULL
in	NULL
NF-kB	NULL
DNA	NULL
binding	NULL
sites	NULL
has	NULL
absent	NULL
or	NULL
sub-optimal	NULL
replication	NULL
in	NULL
different	NULL
in	NULL
vitro	NULL
models	NULL
(	NULL
1	NULL
,	NULL
31	NULL
,	NULL
37	NULL
,	NULL
45	NULL
,	NULL
48	NULL
)	NULL
,	NULL
and	NULL
blocking	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-KB	NULL
or	NULL
its	NULL
binding	NULL
to	NULL
cis-acting	NULL
sequences	NULL
results	NULL
in	NULL
decreased	NULL
HIV	NULL
replication	NULL
(	NULL
28	NULL
,	NULL
30	NULL
,	NULL
50	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
Tat	NULL
,	NULL
the	NULL
regulatory	NULL
viral	NULL
protein	NULL
involved	NULL
in	NULL
regulating	NULL
viral	NULL
replication	NULL
,	NULL
interacts	NULL
directly	NULL
or	NULL
indirectly	NULL
with	NULL
the	NULL
LTR	NULL
NF-	NULL
«	NULL
B	NULL
motif	NULL
(	NULL
5	NULL
,	NULL
53	NULL
,	NULL
57	NULL
)	NULL
.	NULL

All	NULL
the	NULL
above	NULL
data	NULL
suggest	NULL
that	NULL
HIV	NULL
infection	NULL
of	NULL
macrophages	NULL
results	NULL
in	NULL
the	NULL
modification	NULL
of	NULL
signal	NULL
transduction	NULL
pathways	NULL
and	NULL
transcription	NULL
factors	NULL
to	NULL
create	NULL
a	NULL
favorable	NULL
environment	NULL
for	NULL
its	NULL
own	NULL
replication	NULL
;	NULL
HIV-induced	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
may	NULL
be	NULL
one	NULL
of	NULL
the	NULL
mechanisms	NULL
regulating	NULL
viral	NULL
persistence	NULL
in	NULL
these	NULL
host	NULL
cells	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
is	NULL
a	NULL
heterodimeric	NULL
protein	NULL
complex	NULL
involved	NULL
in	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
multiple	NULL
cellular	NULL
and	NULL
viral	NULL
genes	NULL
(	NULL
reviewed	NULL
in	NULL
reference	NULL
3	NULL
)	NULL
.	NULL

One	NULL
common	NULL
feature	NULL
of	NULL
the	NULL
Rel	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
is	NULL
their	NULL
anchoring	NULL
in	NULL
the	NULL
cytosol	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Division	NULL
of	NULL
Experimental	NULL
Pathology	NULL
,	NULL
Mayo	NULL
Clinic	NULL
,	NULL
200	NULL
First	NULL
St.	NULL
SW	NULL
,	NULL
Guggenheim	NULL
501	NULL
,	NULL
Rochester	NULL
,	NULL
MN	NULL
55905	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
507	NULL
)	NULL
284-3747	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
507	NULL
)	NULL
284-3757	NULL
.	NULL

Electronic	NULL
mail	NULL
address	NULL
:	NULL
PAYA	NULL
@	NULL
MAYO.EDU	NULL
.	NULL

223	NULL
by	NULL
various	NULL
inhibitory	NULL
molecules	NULL
or	NULL
IxB	NULL
(	NULL
reviewed	NULL
in	NULL
reference	NULL
35	NULL
)	NULL
.	NULL

IxBa	NULL
,	NULL
a	NULL
35-	NULL
to	NULL
38-kDa	NULL
protein	NULL
,	NULL
anchors	NULL
the	NULL
prototype	NULL
NF-kB	NULL
(	NULL
p50/p65	NULL
)	NULL
by	NULL
masking	NULL
the	NULL
nuclear	NULL
localization	NULL
signal	NULL
of	NULL
p65	NULL
(	NULL
4	NULL
,	NULL
18	NULL
,	NULL
25	NULL
)	NULL
.	NULL

A	NULL
large	NULL
number	NULL
of	NULL
stimuli	NULL
,	NULL
including	NULL
soluble	NULL
cytokines	NULL
,	NULL
various	NULL
second	NULL
messengers	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
an	NULL
array	NULL
of	NULL
cell	NULL
surface	NULL
receptors	NULL
,	NULL
and	NULL
viruses	NULL
,	NULL
result	NULL
in	NULL
posttranslational	NULL
modifications	NULL
of	NULL
IxBa	NULL
«	NULL
and	NULL
subsequent	NULL
NF-kB	NULL
activation	NULL
(	NULL
reviewed	NULL
in	NULL
references	NULL
3	NULL
and	NULL
35	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
still	NULL
unclear	NULL
how	NULL
multiple	NULL
and	NULL
unrelated	NULL
signal	NULL
transduction	NULL
pathways	NULL
target	NULL
IxBa	NULL
.	NULL

Both	NULL
phosphorylation	NULL
and	NULL
subsequent	NULL
degradation	NULL
of	NULL
IxBa	NULL
following	NULL
activation	NULL
of	NULL
different	NULL
cells	NULL
by	NULL
different	NULL
stimuli	NULL
are	NULL
necessary	NULL
for	NULL
the	NULL
release	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
its	NULL
subsequent	NULL
nuclear	NULL
translocation	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
.	NULL

In	NULL
vitro	NULL
,	NULL
multiple	NULL
kinases	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
phosphorylate	NULL
IkxBa	NULL
,	NULL
including	NULL
,	NULL
among	NULL
others	NULL
,	NULL
protein	NULL
kinase	NULL
C-	NULL
«	NULL
(	NULL
PKC-a	NULL
)	NULL
(	NULL
22	NULL
,	NULL
54	NULL
)	NULL
,	NULL
PKA	NULL
(	NULL
22	NULL
,	NULL
54	NULL
)	NULL
,	NULL
p38	NULL
(	NULL
24	NULL
)	NULL
,	NULL
PKC-L-associated	NULL
kinases	NULL
(	NULL
11	NULL
)	NULL
,	NULL
and	NULL
Raf-1	NULL
(	NULL
33	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
variety	NULL
of	NULL
other	NULL
second	NULL
messengers	NULL
that	NULL
function	NULL
within	NULL
multiple	NULL
signal	NULL
transduction	NULL
pathways	NULL
such	NULL
as	NULL
p21	NULL
'	NULL
``	NULL
``	NULL
,	NULL
Raf-1	NULL
,	NULL
src	NULL
,	NULL
and	NULL
PKC-dependent	NULL
and	NULL
-independent	NULL
pathways	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
regulate	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
(	NULL
9	NULL
,	NULL
15-17	NULL
,	NULL
33	NULL
,	NULL
39	NULL
)	NULL
.	NULL

human	NULL
pathogenic	NULL
viruses	NULL
other	NULL
than	NULL
HIV	NULL
activate	NULL
NF-kB	NULL
.	NULL

Examples	NULL
include	NULL
the	NULL
Tax	NULL
protein	NULL
of	NULL
human	NULL
T-lymphotropic	NULL
virus	NULL
type	NULL
1	NULL
and	NULL
the	NULL
LMP-1	NULL
protein	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
29	NULL
,	NULL
32	NULL
)	NULL
.	NULL

Although	NULL
these	NULL
two	NULL
viral	NULL
proteins	NULL
target	NULL
it	NULL
is	NULL
yet	NULL
unknown	NULL
which	NULL
signal	NULL
transduction	NULL
pathway	NULL
(	NULL
s	NULL
)	NULL
is	NULL
being	NULL
activated	NULL
(	NULL
26	NULL
,	NULL
55	NULL
)	NULL
.	NULL

For	NULL
HIV	NULL
,	NULL
not	NULL
only	NULL
are	NULL
the	NULL
signal	NULL
transduction	NULL
pathways	NULL
unknown	NULL
,	NULL
but	NULL
in	NULL
addition	NULL
what	NULL
viral	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
exerts	NULL
this	NULL
action	NULL
remains	NULL
to	NULL
be	NULL
elucidated	NULL
.	NULL

Initial	NULL
studies	NULL
by	NULL
our	NULL
group	NULL
demonstrated	NULL
that	NULL
HIV	NULL
infection	NULL
activates	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
monocytic	NULL
cells	NULL
by	NULL
using	NULL
classical	NULL
PKC	NULL
(	NULL
cPKC	NULL
)	NULL
-independent	NULL
pathways	NULL
(	NULL
46	NULL
)	NULL
.	NULL

At	NULL
least	NULL
12	NULL
PKC	NULL
isoforms	NULL
have	NULL
been	NULL
cloned	NULL
.	NULL

224	NULL
FOLGUEIRA	NULL
ET	NULL
AL	NULL
.	NULL

They	NULL
include	NULL
the	NULL
phospholipid-	NULL
,	NULL
diacylglycerol-	NULL
,	NULL
and	NULL
Ca**-de-pendent	NULL
PKC	NULL
or	NULL
cPKC	NULL
isoenzymes	NULL
(	NULL
«	NULL
,	NULL
BI	NULL
and	NULL
BI	NULL
,	NULL
and	NULL
y	NULL
)	NULL
;	NULL
the	NULL
novel	NULL
PKC	NULL
(	NULL
nPKC	NULL
)	NULL
isoenzymes	NULL
(	NULL
8	NULL
,	NULL
g	NULL
,	NULL
and	NULL
m	NULL
)	NULL
,	NULL
which	NULL
are	NULL
Ca**	NULL
insensitive	NULL
;	NULL
and	NULL
atypical	NULL
PKC	NULL
(	NULL
aPKC	NULL
)	NULL
isoenzymes	NULL
(	NULL
{	NULL
)	NULL
,	NULL
which	NULL
are	NULL
insensitive	NULL
to	NULL
both	NULL
Ca**	NULL
``	NULL
and	NULL
diacylglycerol	NULL
(	NULL
reviewed	NULL
in	NULL
reference	NULL
43	NULL
)	NULL
.	NULL

Of	NULL
these	NULL
PKC	NULL
isoforms	NULL
,	NULL
PKC-£	NULL
clearly	NULL
participates	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
NF-kB	NULL
in	NULL
different	NULL
cell	NULL
systems	NULL
,	NULL
as	NULL
demonstrated	NULL
by	NULL
the	NULL
use	NULL
of	NULL
antisense	NULL
oligonucleotides	NULL
and	NULL
of	NULL
negative	NULL
transdominant	NULL
molecules	NULL
that	NULL
inhibit	NULL
PKC-£	NULL
function	NULL
(	NULL
10	NULL
,	NULL
14	NULL
,	NULL
36	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
PKC-£	NULL
is	NULL
associated	NULL
with	NULL
an	NULL
kinase	NULL
activity	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
exact	NULL
location	NULL
of	NULL
PKC-£	NULL
within	NULL
identified	NULL
signal	NULL
transduction	NULL
pathways	NULL
is	NULL
the	NULL
subject	NULL
of	NULL
active	NULL
study	NULL
,	NULL
to	NULL
date	NULL
this	NULL
kinase	NULL
has	NULL
been	NULL
placed	NULL
downstream	NULL
of	NULL
p21'**	NULL
(	NULL
12	NULL
)	NULL
,	NULL
phosphatidylinositol	NULL
kinase	NULL
(	NULL
PI-3	NULL
kinase	NULL
)	NULL
(	NULL
42	NULL
,	NULL
59	NULL
)	NULL
,	NULL
phosphatidic	NULL
acid	NULL
(	NULL
34	NULL
)	NULL
,	NULL
and	NULL
ceramide	NULL
(	NULL
40	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
specific	NULL
substrates	NULL
and	NULL
downstream	NULL
second	NULL
messengers	NULL
of	NULL
PKC-£	NULL
remain	NULL
unknown	NULL
.	NULL

To	NULL
continue	NULL
our	NULL
investigation	NULL
of	NULL
the	NULL
signal	NULL
transduction	NULL
pathways	NULL
which	NULL
are	NULL
upregulated	NULL
by	NULL
HIV	NULL
in	NULL
monocytic	NULL
cells	NULL
and	NULL
human	NULL
macrophages	NULL
to	NULL
result	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
NF-kB	NULL
and	NULL
thus	NULL
test	NULL
the	NULL
hypothesis	NULL
that	NULL
this	NULL
virus-induced	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
relevant	NULL
for	NULL
its	NULL
replication	NULL
and	NULL
persistence	NULL
in	NULL
this	NULL
host	NULL
cell	NULL
,	NULL
we	NULL
have	NULL
focused	NULL
on	NULL
the	NULL
role	NULL
of	NULL
aPKC	NULL
isoenzymes	NULL
,	NULL
such	NULL
as	NULL
PKC-	NULL
,	NULL
in	NULL
potentially	NULL
mediating	NULL
this	NULL
activation	NULL
.	NULL

For	NULL
this	NULL
,	NULL
we	NULL
have	NULL
used	NULL
a	NULL
model	NULL
of	NULL
persistent	NULL
HIV	NULL
infection	NULL
of	NULL
U937	NULL
cells	NULL
previously	NULL
shown	NULL
to	NULL
contain	NULL
increased	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
as	NULL
a	NULL
result	NULL
of	NULL
posttranslational	NULL
modifications	NULL
of	NULL
IkBa	NULL
«	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Our	NULL
studies	NULL
indicate	NULL
that	NULL
PKC-£	NULL
is	NULL
present	NULL
in	NULL
monocytic	NULL
cells	NULL
and	NULL
that	NULL
its	NULL
interruption	NULL
by	NULL
using	NULL
different	NULL
antisense	NULL
and	NULL
negative	NULL
transdominant	NULL
approaches	NULL
results	NULL
in	NULL
a	NULL
selective	NULL
decrease	NULL
in	NULL
HIV-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
and	NULL
a	NULL
decrease	NULL
in	NULL
HIV	NULL
replication	NULL
in	NULL
human	NULL
macrophages	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
lines	NULL
and	NULL
reagents	NULL
.	NULL

U937	NULL
cells	NULL
were	NULL
purchased	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
,	NULL
Rockville	NULL
,	NULL
Md	NULL
.	NULL

,	NULL
grown	NULL
in	NULL
RPMI	NULL
supplemented	NULL
with	NULL
antibi-otics	NULL
,	NULL
glutamine	NULL
,	NULL
and	NULL
5	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
FBS	NULL
)	NULL
(	NULL
Clontech	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
Calif.	NULL
)	NULL
;	NULL
and	NULL
routinely	NULL
tested	NULL
to	NULL
be	NULL
mycoplasma	NULL
negative	NULL
.	NULL

Phorbol	NULL
myristate	NULL
acetate	NULL
(	NULL
PMA	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Sigma	NULL
Chemicals	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
Mo	NULL
.	NULL

,	NULL
and	NULL
stored	NULL
in	NULL
dimethyl	NULL
sulfoxide	NULL
at	NULL
-20°C	NULL
.	NULL

Lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
GIBCO-BRL	NULL
,	NULL
Gaithersburg	NULL
,	NULL
Md	NULL
.	NULL

,	NULL
and	NULL
stored	NULL
at	NULL
-20°C	NULL
.	NULL

Plasmids	NULL
,	NULL
expression	NULL
vectors	NULL
,	NULL
and	NULL
oligonucleotides	NULL
.	NULL

The	NULL
minimal	NULL
promoter-reporter	NULL
construct	NULL
cona-luc	NULL
and	NULL
the	NULL
three	NULL
tandem	NULL
motifs	NULL
of	NULL
the	NULL
HIV	NULL
LTR	NULL
NF-	NULL
«	NULL
B	NULL
cloned	NULL
upstream	NULL
of	NULL
cona-luc	NULL
yielding	NULL
xB	NULL
cona-luc	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
AP1-luc	NULL
,	NULL
CREB-luc	NULL
,	NULL
and	NULL
CMV-luc	NULL
reporter	NULL
genes	NULL
,	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
38	NULL
)	NULL
.	NULL

The	NULL
thymidine	NULL
kinase-B-galactosidase	NULL
reporter	NULL
plasmid	NULL
was	NULL
used	NULL
to	NULL
normalize	NULL
for	NULL
transfection	NULL
efficacy	NULL
and	NULL
was	NULL
purchased	NULL
from	NULL
Clontech	NULL
.	NULL

The	NULL
cytomegalovirus	NULL
(	NULL
CMV	NULL
)	NULL
expression	NULL
vector	NULL
,	NULL
peDNA3	NULL
,	NULL
referred	NULL
to	NULL
in	NULL
this	NULL
study	NULL
as	NULL
CMV	NULL
,	NULL
was	NULL
purchased	NULL
from	NULL
Invitrogen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
Calif	NULL
.	NULL

The	NULL
PKC-f	NULL
mutant	NULL
(	NULL
6	NULL
,	NULL
10	NULL
)	NULL
is	NULL
a	NULL
kinase-deficient	NULL
PKC-	NULL
{	NULL
generated	NULL
by	NULL
a	NULL
substitution	NULL
of	NULL
Lys-275	NULL
for	NULL
tryptophan	NULL
and	NULL
thus	NULL
lacks	NULL
a	NULL
functional	NULL
catalytic	NULL
domain	NULL
.	NULL

This	NULL
gene	NULL
was	NULL
cloned	NULL
downstream	NULL
of	NULL
the	NULL
peDNA3	NULL
to	NULL
yield	NULL
CMV-PKC-	NULL
(	NULL
.	NULL

The	NULL
phosphorothioate	NULL
oligonucleotides	NULL
to	NULL
PKC-	NULL
,	NULL
sense	NULL
(	NULL
ATG	NULL
CCC	NULL
AGC	NULL
AGG	NULL
ACC	NULL
)	NULL
and	NULL
antisense	NULL
(	NULL
GGT	NULL
CCT	NULL
GCT	NULL
GGG	NULL
CAT	NULL
)	NULL
,	NULL
have	NULL
been	NULL
previously	NULL
described	NULL
(	NULL
13	NULL
)	NULL
and	NULL
are	NULL
directed	NULL
to	NULL
the	NULL
translation	NULL
initiation	NULL
codon	NULL
.	NULL

The	NULL
PKC-y	NULL
oligonucleotides	NULL
are	NULL
targeted	NULL
to	NULL
the	NULL
translation	NULL
initiation	NULL
codon	NULL
(	NULL
44	NULL
)	NULL
,	NULL
and	NULL
their	NULL
sequences	NULL
are	NULL
ATG	NULL
GCT	NULL
GAC	NULL
GTT	NULL
TTC	NULL
CCG	NULL
(	NULL
sense	NULL
)	NULL
and	NULL
CGG	NULL
GAA	NULL
AAC	NULL
GTC	NULL
AGC	NULL
CAT	NULL
(	NULL
antisense	NULL
)	NULL
.	NULL

After	NULL
purifi-cation	NULL
,	NULL
oligonucleotides	NULL
were	NULL
dissolved	NULL
in	NULL
sterile	NULL
HEPES	NULL
(	NULL
N-2-hydroxyeth-ylpiperazine-NV'-2-ethanesulfonic	NULL
acid	NULL
)	NULL
-saline	NULL
solution	NULL
,	NULL
divided	NULL
into	NULL
aliquots	NULL
,	NULL
and	NULL
stored	NULL
at	NULL
-20°C	NULL
.	NULL

For	NULL
the	NULL
different	NULL
experiments	NULL
,	NULL
an	NULL
aliquot	NULL
was	NULL
stored	NULL
at	NULL
4°C	NULL
to	NULL
avoid	NULL
cycles	NULL
of	NULL
freezing	NULL
and	NULL
thawing	NULL
.	NULL

Three	NULL
different	NULL
batches	NULL
were	NULL
used	NULL
in	NULL
the	NULL
different	NULL
experiments	NULL
,	NULL
yielding	NULL
similar	NULL
results	NULL
.	NULL

HIV	NULL
infection	NULL
and	NULL
oligonucleotide	NULL
treatment	NULL
.	NULL

Ten	NULL
million	NULL
exponentially	NULL
growing	NULL
U937	NULL
cells	NULL
were	NULL
infected	NULL
as	NULL
previously	NULL
described	NULL
with	NULL
the	NULL
LAVggy	NULL
;	NULL
strain	NULL
(	NULL
38	NULL
)	NULL
.	NULL

These	NULL
cells	NULL
undergo	NULL
a	NULL
phase	NULL
of	NULL
cell	NULL
death	NULL
at	NULL
days	NULL
7	NULL
to	NULL
14	NULL
postinfection	NULL
,	NULL
and	NULL
the	NULL
surviving	NULL
population	NULL
is	NULL
refractory	NULL
to	NULL
HIV-induced	NULL
cell	NULL
death	NULL
in	NULL
that	NULL
a	NULL
productive	NULL
persistent	NULL
infection	NULL
is	NULL
established	NULL
in	NULL
over	NULL
90	NULL
%	NULL
of	NULL
cells	NULL
as	NULL
detected	NULL
by	NULL
fluorescence-activated	NULL
cell	NULL
sorter	NULL
analysis	NULL
directed	NULL
to	NULL
cytoplasmic	NULL
p24	NULL
(	NULL
38	NULL
)	NULL
.	NULL

U937	NULL
cells	NULL
21	NULL
to	NULL
40	NULL
days	NULL
postinfection	NULL
were	NULL
used	NULL
in	NULL
the	NULL
experiments	NULL
.	NULL

Monocyte-derived	NULL
human	NULL
macrophages	NULL
were	NULL
generated	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
buffy	NULL
coats	NULL
from	NULL
normal	NULL
healthy	NULL
donors	NULL
from	NULL
our	NULL
blood	NULL
bank	NULL
were	NULL
processed	NULL
through	NULL
Ficoll-Hypaque	NULL
gradients	NULL
.	NULL

After	NULL
an	NULL
extensive	NULL
washing	NULL
,	NULL
4	NULL
X	NULL
10°	NULL
mononuclear	NULL
cells	NULL
were	NULL
placed	NULL
in	NULL
2	NULL
ml	NULL
of	NULL
RPMI	NULL
with	NULL
10	NULL
%	NULL
human	NULL
sera	NULL
for	NULL
5	NULL
days	NULL
.	NULL

Thereafter	NULL
,	NULL
J.	NULL
ViroL	NULL
.	NULL

nonadherent	NULL
cells	NULL
were	NULL
removed	NULL
by	NULL
extensive	NULL
washing	NULL
and	NULL
the	NULL
adherent	NULL
monocyte-derived	NULL
macrophages	NULL
(	NULL
MDM	NULL
)	NULL
were	NULL
infected	NULL
with	NULL
10°	NULL
cpm	NULL
of	NULL
SF	NULL
;	NULL
,4	NULL
,	NULL
(	NULL
ob-tained	NULL
from	NULL
the	NULL
NIH	NULL
AIDS	NULL
Research	NULL
and	NULL
Reference	NULL
Reagent	NULL
Program	NULL
,	NULL
Rockville	NULL
,	NULL
Md	NULL
.	NULL
)	NULL

in	NULL
0.5	NULL
ml	NULL
of	NULL
RPMI-10	NULL
%	NULL
FBS	NULL
for	NULL
18	NULL
h.	NULL
Cell-free	NULL
virus	NULL
was	NULL
then	NULL
removed	NULL
by	NULL
extensive	NULL
washing	NULL
,	NULL
and	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
different	NULL
oligonucleotides	NULL
at	NULL
1	NULL
M	NULL
or	NULL
left	NULL
untreated	NULL
and	NULL
incubated	NULL
in	NULL
duplicate	NULL
wells	NULL
(	NULL
per	NULL
treatment	NULL
)	NULL
in	NULL
2	NULL
ml	NULL
of	NULL
RPMI	NULL
with	NULL
10	NULL
%	NULL
FBS	NULL
.	NULL

Cells	NULL
were	NULL
passaged	NULL
once	NULL
weekly	NULL
by	NULL
removing	NULL
old	NULL
culture	NULL
supernatant	NULL
and	NULL
adding	NULL
RPMI-10	NULL
%	NULL
FBS	NULL
containing	NULL
or	NULL
not	NULL
containing	NULL
the	NULL
appropriate	NULL
oligonucleotide	NULL
treatment	NULL
.	NULL

At	NULL
each	NULL
passage	NULL
,	NULL
cell	NULL
supernatant	NULL
was	NULL
spun	NULL
at	NULL
1,000	NULL
X	NULL
g	NULL
and	NULL
the	NULL
cell-free	NULL
medium	NULL
was	NULL
frozen	NULL
at	NULL
-20°C	NULL
for	NULL
subsequent	NULL
p24	NULL
determination	NULL
by	NULL
using	NULL
a	NULL
commercial	NULL
p24	NULL
assay	NULL
kit	NULL
(	NULL
Cellular	NULL
Products	NULL
,	NULL
Buffalo	NULL
,	NULL
N.Y.	NULL
)	NULL
.	NULL

Cell	NULL
transfections	NULL
.	NULL

Transfection	NULL
of	NULL
U937	NULL
cells	NULL
was	NULL
performed	NULL
by	NULL
using	NULL
DEAE-dextran	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Exponentially	NULL
growing	NULL
cells	NULL
were	NULL
washed	NULL
in	NULL
TS	NULL
buffer	NULL
(	NULL
46	NULL
)	NULL
and	NULL
resuspended	NULL
at	NULL
6	NULL
X	NULL
10°	NULL
cells	NULL
in	NULL
600	NULL
pl	NULL
of	NULL
TS	NULL
containing	NULL
the	NULL
different	NULL
plasmids	NULL
and/or	NULL
oligonucleotides	NULL
and	NULL
DEAE-dextran	NULL
(	NULL
Pharmacia	NULL
,	NULL
Pis-cataway	NULL
,	NULL
N.J.	NULL
)	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
0.5	NULL
mg/ml	NULL
for	NULL
20	NULL
min	NULL
at	NULL
21°C	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
washed	NULL
in	NULL
RPMI	NULL
1640	NULL
,	NULL
and	NULL
4	NULL
x	NULL
10®	NULL
were	NULL
resuspended	NULL
in	NULL
RPMI	NULL
1640-5	NULL
%	NULL
FBS	NULL
at	NULL
5	NULL
X	NULL
10°/ml	NULL
per	NULL
well	NULL
in	NULL
6-well	NULL
plates	NULL
(	NULL
Costar	NULL
,	NULL
Cambridge	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

.	NULL

One	NULL
additional	NULL
aliquot	NULL
of	NULL
2	NULL
X	NULL
10°	NULL
cells	NULL
was	NULL
resuspended	NULL
in	NULL
RPMI	NULL
1640-5	NULL
%	NULL
FBS	NULL
at	NULL
10°/ml	NULL
per	NULL
well	NULL
in	NULL
24-well	NULL
plates	NULL
.	NULL

Stimuli	NULL
including	NULL
PMA	NULL
(	NULL
20	NULL
ng/m	NULL
!	NULL
)	NULL

and	NULL
LPS	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
were	NULL
added	NULL
36	NULL
h	NULL
after	NULL
transfection	NULL
.	NULL

Twenty-four	NULL
hours	NULL
posttransfection	NULL
,	NULL
the	NULL
2	NULL
X	NULL
10°	NULL
aliquot	NULL
was	NULL
harvested	NULL
,	NULL
washed	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
,	NULL
and	NULL
lysed	NULL
in	NULL
lysis	NULL
buffer	NULL
(	NULL
Clontech	NULL
)	NULL
,	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
recommendations	NULL
to	NULL
detect	NULL
B-galactosidase	NULL
activity	NULL
.	NULL

The	NULL
4	NULL
X	NULL
10°	NULL
aliquot	NULL
was	NULL
harvested	NULL
48	NULL
h	NULL
posttransfection	NULL
,	NULL
washed	NULL
in	NULL
PBS	NULL
,	NULL
and	NULL
then	NULL
lysed	NULL
in	NULL
a	NULL
luciferase	NULL
lysis	NULL
buffer	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
recommendations	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
Wis.	NULL
)	NULL
to	NULL
detect	NULL
luciferase	NULL
activity	NULL
.	NULL

In	NULL
both	NULL
aliquots	NULL
,	NULL
total	NULL
protein	NULL
content	NULL
was	NULL
measured	NULL
by	NULL
the	NULL
Bradford	NULL
technique	NULL
with	NULL
the	NULL
Bio-Rad	NULL
kit	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Hercules	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

Transfection	NULL
results	NULL
are	NULL
expressed	NULL
as	NULL
relative	NULL
light	NULL
units	NULL
,	NULL
the	NULL
ratio	NULL
of	NULL
luciferase	NULL
to	NULL
B-galactosidase	NULL
units	NULL
normalized	NULL
to	NULL
total	NULL
protein	NULL
.	NULL

Each	NULL
set	NULL
of	NULL
experiments	NULL
was	NULL
done	NULL
at	NULL
least	NULL
three	NULL
times	NULL
with	NULL
different	NULL
plasmids	NULL
and	NULL
oligonucleotide	NULL
preparations	NULL
.	NULL

Immunoblotting	NULL
.	NULL

Forty	NULL
micrograms	NULL
of	NULL
each	NULL
cell	NULL
lysate	NULL
was	NULL
analyzed	NULL
by	NULL
sodium	NULL
dodecy	NULL
]	NULL
sulfate-10	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
SDS-10	NULL
%	NULL
PAGE	NULL
)	NULL
and	NULL
then	NULL
transferred	NULL
to	NULL
Immobilon	NULL
membranes	NULL
(	NULL
Millipore	NULL
,	NULL
Bedford	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

and	NULL
immunoblotted	NULL
with	NULL
specific	NULL
antibodies	NULL
.	NULL

Anti-PKC	NULL
isoenzyme	NULL
antibodies	NULL
and	NULL
corresponding	NULL
peptides	NULL
were	NULL
purchased	NULL
from	NULL
GIBCO-BRL	NULL
.	NULL

Antibody	NULL
to	NULL
the	NULL
p85	NULL
subunit	NULL
of	NULL
PI-3	NULL
kinase	NULL
was	NULL
a	NULL
kind	NULL
gift	NULL
from	NULL
Robert	NULL
Abraham	NULL
(	NULL
Mayo	NULL
Clinic	NULL
)	NULL
.	NULL

Immunoblotting	NULL
was	NULL
detected	NULL
by	NULL
using	NULL
the	NULL
ECL	NULL
kit	NULL
(	NULL
Amersham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
III	NULL
.	NULL
)	NULL

.	NULL

RESULTS	NULL
PKC-£	NULL
is	NULL
present	NULL
in	NULL
U937	NULL
cells	NULL
and	NULL
is	NULL
inhibited	NULL
with	NULL
specific	NULL
antisense	NULL
oligonucleotides	NULL
.	NULL

Having	NULL
previously	NULL
demonstrated	NULL
that	NULL
persistent	NULL
HIV	NULL
infection	NULL
of	NULL
U937	NULL
cells	NULL
results	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
a	NULL
cPKC-independent	NULL
fashion	NULL
(	NULL
46	NULL
)	NULL
,	NULL
we	NULL
determined	NULL
whether	NULL
PKC	NULL
isoenzymes	NULL
other	NULL
than	NULL
those	NULL
susceptible	NULL
to	NULL
the	NULL
PKC	NULL
inhibitor	NULL
GF	NULL
(	NULL
60	NULL
)	NULL
that	NULL
could	NULL
mediate	NULL
NF-kB	NULL
activation	NULL
were	NULL
present	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

To	NULL
date	NULL
,	NULL
only	NULL
the	NULL
aPKC-£	NULL
isoenzyme	NULL
has	NULL
been	NULL
clearly	NULL
identified	NULL
to	NULL
participate	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
NF-B	NULL
in	NULL
different	NULL
cell	NULL
lines	NULL
(	NULL
10	NULL
,	NULL
14	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Total	NULL
cell	NULL
lysates	NULL
of	NULL
U937	NULL
cells	NULL
and	NULL
rat	NULL
brain	NULL
homogenate	NULL
were	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
immunoblotted	NULL
with	NULL
polyclonal	NULL
antibodies	NULL
directed	NULL
to	NULL
different	NULL
PKC	NULL
isoenzymes	NULL
.	NULL

Within	NULL
the	NULL
group	NULL
of	NULL
cPKC	NULL
isoenzymes	NULL
,	NULL
only	NULL
PKC-y	NULL
was	NULL
detected	NULL
in	NULL
U937	NULL
lysates	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
lane	NULL
9	NULL
)	NULL
,	NULL
while	NULL
PKC-	NULL
«	NULL
,	NULL
-BI	NULL
and	NULL
-BII	NULL
,	NULL
and	NULL
-y	NULL
were	NULL
present	NULL
in	NULL
the	NULL
rat	NULL
brain	NULL
homogenate	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
lanes	NULL
2	NULL
,	NULL
5	NULL
,	NULL
and	NULL
10	NULL
)	NULL
.	NULL

The	NULL
specificities	NULL
of	NULL
the	NULL
80-kDa	NULL
cPKC	NULL
isoenzymes	NULL
were	NULL
determined	NULL
by	NULL
preincubating	NULL
each	NULL
antibody	NULL
preparation	NULL
with	NULL
the	NULL
specific	NULL
peptide	NULL
prior	NULL
to	NULL
immunoblotting	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
lanes	NULL
3	NULL
,	NULL
4	NULL
,	NULL
7	NULL
,	NULL
8	NULL
,	NULL
11	NULL
,	NULL
and	NULL
12	NULL
)	NULL
.	NULL

We	NULL
next	NULL
examined	NULL
whether	NULL
nPKC	NULL
isoenzymes	NULL
such	NULL
as	NULL
PKC-8	NULL
and	NULL
-g	NULL
were	NULL
present	NULL
in	NULL
this	NULL
cell	NULL
line	NULL
.	NULL

Using	NULL
specific	NULL
antibodies	NULL
and	NULL
competing	NULL
peptides	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
the	NULL
80-kDa	NULL
PKC-8	NULL
and	NULL
the	NULL
90-kDa	NULL
PKC-g	NULL
were	NULL
present	NULL
in	NULL
rat	NULL
brain	NULL
but	NULL
not	NULL
in	NULL
U937	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
lanes	NULL
13	NULL
and	NULL
17	NULL
)	NULL
.	NULL

The	NULL
aPKC	NULL
isoenzyme	NULL
,	NULL
PKC-£	NULL
,	NULL
with	NULL
a	NULL
molecular	NULL
mass	NULL
of	NULL
65	NULL
to	NULL
70	NULL
kDa	NULL
was	NULL
detected	NULL
in	NULL
both	NULL
U937	NULL
cell	NULL
lysates	NULL
and	NULL
rat	NULL
brain	NULL
homogenate	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
lanes	NULL
21	NULL
and	NULL
22	NULL
)	NULL
.	NULL

The	NULL
nature	NULL
of	NULL
the	NULL
double	NULL
band	NULL
detected	NULL
by	NULL
anti-PKC-£	NULL
antibodies	NULL
is	NULL
unclear	NULL
at	NULL
this	NULL
time	NULL
,	NULL
although	NULL
it	NULL
has	NULL
been	NULL
observed	NULL
by	NULL
other	NULL
authors	NULL
to	NULL
occur	NULL
in	NULL
COS	NULL
cells	NULL
(	NULL
61	NULL
)	NULL
and	NULL
is	NULL
suggested	NULL
to	NULL
be	NULL
an	NULL
effect	NULL
of	NULL
proteolysis	NULL
.	NULL

Alter-natively	NULL
,	NULL
the	NULL
anti-PKC-£	NULL
antibody	NULL
could	NULL
cross-react	NULL
with	NULL
another	NULL
recently	NULL
described	NULL
member	NULL
of	NULL
the	NULL
aPKC	NULL
isoenzyme	NULL
voL	NULL
.	NULL

70	NULL
,	NULL
1996	NULL
PKC-	NULL
«	NULL
PKC-	NULL
LH	NULL
PKC-y	NULL
;	NULL
Comp	NULL
;	NULL
_	NULL
Comp	NULL
.	NULL

;	NULL
Comp	NULL
.	NULL

U	NULL
;	NULL
B	NULL
;	NULL
U	NULL
_	NULL
;	NULL
B	NULL
[	NULL
U	NULL
;	NULL
Bj	NULL
U	NULL
,	NULL
;	NULL
B	NULL
|	NULL
U	NULL
,	NULL
B	NULL
;	NULL
U	NULL
,	NULL
;	NULL
B	NULL
97	NULL
kd	NULL
-	NULL
#	NULL
A	NULL
U	NULL
«	NULL
amuse	NULL
--	NULL
-	NULL
6	NULL
_	NULL
:	NULL
*	NULL
wees	NULL
P	NULL
_	NULL
#	NULL
*	NULL
68	NULL
kd	NULL
-	NULL
f	NULL
10	NULL
%	NULL
3	NULL
40	NULL
50	NULL
60	NULL
708	NULL
9	NULL
10	NULL
_	NULL
110	NULL
12	NULL
PKC-5	NULL
PKC-e	NULL
PKC-	NULL
;	NULL
Comp	NULL
.	NULL

,	NULL
_	NULL
Comp	NULL
;	NULL
Comp	NULL
.	NULL

B	NULL
,	NULL
U	NULL
,	NULL
;	NULL
B	NULL
;	NULL
UJ	NULL
B	NULL
,	NULL
Uj	NULL
B	NULL
;	NULL
U	NULL
|	NULL
B	NULL
;	NULL
Uj	NULL
;	NULL
B	NULL
;	NULL
U	NULL
97	NULL
kd	NULL
-	NULL
camp	NULL
*	NULL
#	NULL
‘	NULL
.	NULL

Wich	NULL
wrue	NULL
v	NULL
F	NULL
68	NULL
kd	NULL
-	NULL
«	NULL
a	NULL
G-13	NULL
140	NULL
15	NULL
16	NULL
17	NULL
180	NULL
19	NULL
¥	NULL
0	NULL
2	NULL
0	NULL
20	NULL
23	NULL
24	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

PKC	NULL
isoenzymes	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

Forty	NULL
micrograms	NULL
of	NULL
cell	NULL
lysates	NULL
from	NULL
U937	NULL
cells	NULL
(	NULL
U	NULL
)	NULL
and	NULL
rat	NULL
brain	NULL
homogenate	NULL
(	NULL
B	NULL
)	NULL
were	NULL
analyzed	NULL
by	NULL
SDS-10	NULL
%	NULL
PAGE	NULL
followed	NULL
by	NULL
immunoblotting	NULL
with	NULL
specific	NULL
polyclonal	NULL
antibodies	NULL
directed	NULL
against	NULL
the	NULL
different	NULL
PKC	NULL
isoenzymes	NULL
.	NULL

Antibody	NULL
was	NULL
preincubated	NULL
with	NULL
a	NULL
10-fold	NULL
(	NULL
wt/wt	NULL
)	NULL
excess	NULL
amount	NULL
of	NULL
peptide	NULL
prior	NULL
to	NULL
immunoblotting	NULL
(	NULL
Comp	NULL
)	NULL
.	NULL

(	NULL
Top	NULL
)	NULL
cPKC	NULL
isoenzymes	NULL
(	NULL
a	NULL
,	NULL
BI	NULL
and	NULL
BIL	NULL
,	NULL
and	NULL
y	NULL
)	NULL
;	NULL
(	NULL
bottom	NULL
)	NULL
nPKC	NULL
isoenzymes	NULL
(	NULL
8	NULL
and	NULL
£	NULL
)	NULL
and	NULL
aPKC	NULL
isoenzymes	NULL
(	NULL
{	NULL
)	NULL
.	NULL

The	NULL
molecular	NULL
markers	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
left	NULL
,	NULL
and	NULL
each	NULL
isoenzyme	NULL
is	NULL
marked	NULL
with	NULL
a	NULL
dot	NULL
.	NULL

group	NULL
(	NULL
PKC-	NULL
)	NULL
(	NULL
52	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
HIV	NULL
-induced	NULL
cPKC-independent	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
U937	NULL
cells	NULL
could	NULL
be	NULL
potentially	NULL
mediated	NULL
by	NULL
PKC-£	NULL
.	NULL

Because	NULL
of	NULL
the	NULL
lack	NULL
of	NULL
specific	NULL
pharmacological	NULL
inhibitors	NULL
that	NULL
target	NULL
PKC-£	NULL
function	NULL
,	NULL
we	NULL
investigated	NULL
whether	NULL
oligonucleotides	NULL
directed	NULL
to	NULL
the	NULL
translational	NULL
initiation	NULL
codon	NULL
of	NULL
the	NULL
RNA	NULL
of	NULL
this	NULL
isoenzyme	NULL
,	NULL
previously	NULL
shown	NULL
to	NULL
inhibit	NULL
its	NULL
function	NULL
(	NULL
13	NULL
)	NULL
,	NULL
would	NULL
be	NULL
useful	NULL
to	NULL
interfere	NULL
with	NULL
its	NULL
function	NULL
in	NULL
the	NULL
U937	NULL
cell	NULL
line	NULL
.	NULL

Sense	NULL
and	NULL
antisense	NULL
phosphorothioate	NULL
oligonucleotides	NULL
specific	NULL
for	NULL
the	NULL
PKC-£	NULL
sequence	NULL
were	NULL
added	NULL
at	NULL
different	NULL
concentrations	NULL
to	NULL
exponentially	NULL
growing	NULL
U937	NULL
cells	NULL
for	NULL
36	NULL
h	NULL
,	NULL
after	NULL
which	NULL
cells	NULL
were	NULL
harvested	NULL
,	NULL
analyzed	NULL
for	NULL
viability	NULL
,	NULL
and	NULL
lysed	NULL
.	NULL

Viability	NULL
and	NULL
total	NULL
cell	NULL
numbers	NULL
were	NULL
similar	NULL
to	NULL
those	NULL
for	NULL
mock-treated	NULL
cells	NULL
for	NULL
the	NULL
different	NULL
concentrations	NULL
of	NULL
sense	NULL
and	NULL
antisense	NULL
oligonucleotides	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

An	NULL
equal	NULL
amount	NULL
of	NULL
protein	NULL
cell	NULL
lysate	NULL
from	NULL
each	NULL
concentration	NULL
of	NULL
oligonucleotide	NULL
was	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
followed	NULL
by	NULL
immunoblotting	NULL
with	NULL
anti-PKC-£	NULL
antibodies	NULL
.	NULL

One-hundred-micromolar	NULL
concentrations	NULL
of	NULL
antisense	NULL
but	NULL
not	NULL
sense	NULL
oligonucleotides	NULL
to	NULL
PKC-£	NULL
inhibited	NULL
the	NULL
expression	NULL
of	NULL
this	NULL
kinase	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Despite	NULL
the	NULL
apparent	NULL
lack	NULL
of	NULL
effect	NULL
of	NULL
100	NULL
uM	NULL
antisense	NULL
oligonucleotide	NULL
to	NULL
PKC-£	NULL
on	NULL
cell	NULL
viability	NULL
and	NULL
growth	NULL
of	NULL
U937	NULL
,	NULL
we	NULL
tested	NULL
whether	NULL
the	NULL
synthesis	NULL
of	NULL
cellular	NULL
proteins	NULL
unrelated	NULL
to	NULL
PKC-£	NULL
could	NULL
be	NULL
inhibited	NULL
nonspecifically	NULL
.	NULL

By	NULL
immunoblotting	NULL
the	NULL
same	NULL
cellular	NULL
lysates	NULL
with	NULL
an	NULL
anti-p85	NULL
antibody	NULL
that	NULL
recognizes	NULL
the	NULL
p85	NULL
subunit	NULL
of	NULL
PI-3	NULL
kinase	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
synthesis	NULL
of	NULL
this	NULL
protein	NULL
is	NULL
not	NULL
inhibited	NULL
by	NULL
antisense	NULL
PKC-£	NULL
oligonucleotides	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

In	NULL
repetitive	NULL
experiments	NULL
,	NULL
the	NULL
inhibitory	NULL
dose	NULL
of	NULL
PKC-£	NULL
antisense	NULL
oligonucleotides	NULL
ranged	NULL
from	NULL
75	NULL
to	NULL
100	NULL
mM	NULL
.	NULL

Antisense	NULL
oligonucleotides	NULL
to	NULL
PKC-	NULL
interfere	NULL
with	NULL
the	NULL
HIV-induced	NULL
NF-KB	NULL
activation	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
persistently	NULL
infected	NULL
U937	NULL
cells	NULL
and	NULL
human	NULL
macrophages	NULL
contain	NULL
increased	NULL
NF-kB	NULL
functional	NULL
activity	NULL
as	NULL
measured	NULL
by	NULL
NF-kB-dependent	NULL
reporter	NULL
genes	NULL
(	NULL
38	NULL
,	NULL
46	NULL
)	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
such	NULL
activity	NULL
is	NULL
mediated	NULL
by	NULL
PKC-£	NULL
,	NULL
we	NULL
developed	NULL
PKC-f	NULL
MEDIATES	NULL
NF-	NULL
«	NULL
B	NULL
ACTIVATION	NULL
IN	NULL
MONOCYTES	NULL
225	NULL
a	NULL
model	NULL
in	NULL
which	NULL
oligonucleotides	NULL
could	NULL
be	NULL
transfected	NULL
con-comitantly	NULL
with	NULL
reporter	NULL
genes	NULL
rather	NULL
than	NULL
being	NULL
added	NULL
to	NULL
the	NULL
transfected	NULL
cell	NULL
culture	NULL
,	NULL
thus	NULL
significantly	NULL
reducing	NULL
the	NULL
amount	NULL
of	NULL
oligonucleotide	NULL
required	NULL
and	NULL
potential	NULL
variability	NULL
in	NULL
their	NULL
uptake	NULL
by	NULL
cells	NULL
.	NULL

Mock-	NULL
and	NULL
HIV-infected	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
minimal	NULL
conalbumin	NULL
promoter-luciferase	NULL
reporter	NULL
gene	NULL
(	NULL
cona-luc	NULL
)	NULL
or	NULL
with	NULL
the	NULL
same	NULL
construct	NULL
containing	NULL
three	NULL
NF-kB	NULL
tandem	NULL
motifs	NULL
of	NULL
the	NULL
HIV	NULL
LTR	NULL
(	NULL
3	NULL
kB	NULL
cona-luc	NULL
)	NULL
and	NULL
10	NULL
pM	NULL
either	NULL
sense	NULL
or	NULL
antisense	NULL
oligonucleotides	NULL
to	NULL
PKC-£	NULL
.	NULL

As	NULL
previously	NULL
reported	NULL
(	NULL
38	NULL
,	NULL
46	NULL
)	NULL
,	NULL
more	NULL
NF-KB	NULL
activity	NULL
is	NULL
present	NULL
in	NULL
HIV-infected	NULL
than	NULL
in	NULL
mock-infected	NULL
U937	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
compare	NULL
``	NULL
mock	NULL
``	NULL
groups	NULL
for	NULL
the	NULL
two	NULL
cell	NULL
lines	NULL
)	NULL
.	NULL

Cotransfection	NULL
of	NULL
PKC-	NULL
antisense	NULL
oligonucleotides	NULL
reduced	NULL
the	NULL
NF-KB	NULL
activity	NULL
present	NULL
in	NULL
HIV-infected	NULL
U937	NULL
cells	NULL
but	NULL
not	NULL
that	NULL
of	NULL
uninfected	NULL
U937	NULL
cells	NULL
.	NULL

The	NULL
PKC-£	NULL
sense	NULL
oligonucleotides	NULL
did	NULL
not	NULL
interfere	NULL
significantly	NULL
with	NULL
NF-	NULL
«	NULL
kB-dependent	NULL
function	NULL
in	NULL
either	NULL
cell	NULL
group	NULL
.	NULL

To	NULL
show	NULL
specificity	NULL
of	NULL
the	NULL
PKC-£	NULL
antisense	NULL
oligonucleotides	NULL
in	NULL
interfering	NULL
with	NULL
the	NULL
HIV-dependent	NULL
NF-kB	NULL
activation	NULL
,	NULL
titration	NULL
of	NULL
the	NULL
oligonucleotide	NULL
concentration	NULL
was	NULL
performed	NULL
with	NULL
HIV-infected	NULL
U937	NULL
cells	NULL
.	NULL

These	NULL
cells	NULL
were	NULL
cotransfected	NULL
either	NULL
with	NULL
the	NULL
cona-lue	NULL
or	NULL
3	NULL
kB	NULL
cona-lue	NULL
reporter	NULL
gene	NULL
and	NULL
increasing	NULL
concentrations	NULL
of	NULL
sense	NULL
or	NULL
antisense	NULL
oligonucleotides	NULL
to	NULL
PKC-	NULL
{	NULL
.	NULL

The	NULL
NF-KB	NULL
activity	NULL
present	NULL
in	NULL
HIV-infected	NULL
cells	NULL
was	NULL
reduced	NULL
with	NULL
an	NULL
increasing	NULL
concentration	NULL
of	NULL
antisense	NULL
but	NULL
not	NULL
sense	NULL
oligonucleotides	NULL
,	NULL
with	NULL
a	NULL
significant	NULL
reduction	NULL
detected	NULL
around	NULL
1	NULL
wM	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
Fig	NULL
.	NULL

3C	NULL
shows	NULL
results	NULL
of	NULL
three	NULL
representative	NULL
experiments	NULL
which	NULL
indicate	NULL
that	NULL
antisense	NULL
oligonucleotides	NULL
to	NULL
PKC-£	NULL
repro-ducibly	NULL
inhibit	NULL
60	NULL
%	NULL
of	NULL
the	NULL
HIV-induced	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
,	NULL
with	NULL
some	NULL
degree	NULL
of	NULL
inhibition	NULL
,	NULL
albeit	NULL
moderate	NULL
(	NULL
15	NULL
%	NULL
)	NULL
,	NULL
being	NULL
observed	NULL
with	NULL
the	NULL
sense	NULL
oligonucleotides	NULL
.	NULL

The	NULL
lower	NULL
concentration	NULL
of	NULL
oligonucleotides	NULL
required	NULL
to	NULL
inhibit	NULL
NF-	NULL
«	NULL
B-dependent	NULL
transcriptional	NULL
activity	NULL
in	NULL
HIV-infected	NULL
cells	NULL
(	NULL
10	NULL
M	NULL
)	NULL
in	NULL
comparison	NULL
with	NULL
that	NULL
required	NULL
to	NULL
inhibit	NULL
PKC-£	NULL
expression	NULL
(	NULL
100	NULL
M	NULL
)	NULL
is	NULL
possibly	NULL
due	NULL
to	NULL
the	NULL
introduction	NULL
of	NULL
oligonucleotides	NULL
by	NULL
transfection	NULL
techniques	NULL
in	NULL
the	NULL
former	NULL
situation	NULL
.	NULL

To	NULL
further	NULL
control	NULL
for	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
PKC-£	NULL
antisense	NULL
oligonucleotides	NULL
to	NULL
inhibit	NULL
HIV-mediated	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
U937	NULL
cells	NULL
,	NULL
we	NULL
generated	NULL
oligonucleotides	NULL
to	NULL
target	NULL
another	NULL
PKC	NULL
isoenzyme	NULL
present	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
PKC-y	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
lane	NULL
9	NULL
)	NULL
.	NULL

In	NULL
experiments	NULL
similar	NULL
to	NULL
those	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
cotransfection	NULL
of	NULL
either	NULL
sense	NULL
or	NULL
antisense	NULL
oligonucleotides	NULL
to	NULL
PKC	NULL
-y	NULL
did	NULL
not	NULL
significantly	NULL
interfere	NULL
with	NULL
the	NULL
HIV-mediated	NULL
NF-kB	NULL
activation	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
the	NULL
antisense	NULL
oligonucleotide	NULL
to	NULL
PKC-£	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
50	NULL
asl	NULL
&	NULL
0	NULL
_	NULL
$	NULL
50	NULL
.	NULL

s100	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Antisense	NULL
oligonucleotide	NULL
to	NULL
PKC-f	NULL
inhibits	NULL
synthesis	NULL
of	NULL
PKC-	NULL
.	NULL

Cells	NULL
(	NULL
5	NULL
x	NULL
10°	NULL
)	NULL
were	NULL
incubated	NULL
in	NULL
2	NULL
ml	NULL
of	NULL
media	NULL
containing	NULL
different	NULL
micromolar	NULL
concentrations	NULL
(	NULL
indicated	NULL
above	NULL
lanes	NULL
)	NULL
of	NULL
the	NULL
sense	NULL
(	NULL
s	NULL
)	NULL
or	NULL
the	NULL
antisense	NULL
(	NULL
as	NULL
)	NULL
oligonucleotides	NULL
directed	NULL
to	NULL
PKC-f	NULL
for	NULL
36	NULL
h.	NULL
Cells	NULL
were	NULL
then	NULL
counted	NULL
,	NULL
lysed	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
followed	NULL
by	NULL
immunoblotting	NULL
with	NULL
PKC-f	NULL
antibodies	NULL
.	NULL

The	NULL
same	NULL
amount	NULL
(	NULL
40	NULL
pg	NULL
)	NULL
of	NULL
cell	NULL
lysate	NULL
was	NULL
loaded	NULL
in	NULL
each	NULL
lane	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
then	NULL
stripped	NULL
and	NULL
reblotted	NULL
with	NULL
anti-p85	NULL
antibodies	NULL
.	NULL

226	NULL
FOLGUEIRA	NULL
ET	NULL
AL	NULL
.	NULL

J.	NULL
ViroL	NULL
.	NULL

A	NULL
.	NULL

mock	NULL
900	NULL
T	NULL
E	NULL
sense	NULL
antisense	NULL
700	NULL
7	NULL
G	NULL
wl	NULL
~	NULL
_	NULL
500	NULL
7	NULL
a	NULL
»	NULL
)	NULL
A	NULL
P	NULL
P4	NULL
m	NULL
=	NULL
100	NULL
7	NULL
cona-lue	NULL
-	NULL
3kB	NULL
cona-luc	NULL
cona-lue	NULL
_	NULL
3KkB	NULL
cona-lue	NULL
U937	NULL
NI	NULL
U937	NULL
HIV	NULL
B	NULL
12000	NULL
10000	NULL
{	NULL
``	NULL
3	NULL
8000	NULL
.	NULL

v	NULL
.	NULL

3	NULL
soe	NULL
{	NULL
2000	NULL
NM	NULL
;	NULL
0	NULL
ol	NULL
O1	NULL
10	NULL
Tol	NULL
O1	NULL
o-	NULL
0	NULL
010	NULL
1	NULL
10	NULL
!	NULL

0l	NULL
1	NULL
10	NULL
sense	NULL
PKC-C	NULL
-_	NULL
antisense	NULL
PKC-C	NULL
sense	NULL
PKC-	NULL
antisense	NULL
PKC-CONA-LUC	NULL
3	NULL
kB	NULL
CONA-LUC	NULL
RLU	NULL
Exp	NULL
.	NULL

#	NULL
1	NULL
Exp	NULL
#	NULL
2	NULL
Exp	NULL
#	NULL
3	NULL
0	NULL
39676	NULL
61925	NULL
129123	NULL
SENSE	NULL
28084	NULL
69292	NULL
120897	NULL
ANTI-SENSE	NULL
-	NULL
13976	NULL
25862	NULL
48887	NULL
SENSE	NULL
ANTE-SENSE	NULL
F	NULL
i	NULL
T	NULL
T	NULL
T	NULL
Y	NULL
T	NULL
bi	NULL
I	NULL
*	NULL
1	NULL
0	NULL
20	NULL
40	NULL
60	NULL
80	NULL
100	NULL
%	NULL
reduction	NULL
voL	NULL
.	NULL

70	NULL
,	NULL
1996	NULL
PKC-f	NULL
MEDIATES	NULL
NF-	NULL
«	NULL
B	NULL
ACTIVATION	NULL
IN	NULL
MONOCYTES	NULL
227	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Antisense	NULL
oligonucleotides	NULL
to	NULL
PKC-f	NULL
inhibit	NULL
the	NULL
HIV-mediated	NULL
NF-xB	NULL
activation	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Uninfected	NULL
(	NULL
Nl	NULL
)	NULL
or	NULL
HIV-infected	NULL
(	NULL
HIV	NULL
)	NULL
U937	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
3	NULL
«	NULL
B	NULL
cona-luc	NULL
or	NULL
the	NULL
control	NULL
cona-lue	NULL
reporter	NULL
gene	NULL
and	NULL
mock	NULL
,	NULL
sense	NULL
,	NULL
or	NULL
antisense	NULL
oligonucleotides	NULL
to	NULL
PKC-	NULL
{	NULL
(	NULL
10	NULL
wM	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
HIV-infected	NULL
U937	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
control	NULL
cona-lue	NULL
and	NULL
the	NULL
3	NULL
xB	NULL
cona-luc	NULL
reporter	NULL
genes	NULL
with	NULL
different	NULL
micromolar	NULL
concentrations	NULL
of	NULL
sense	NULL
or	NULL
antisense	NULL
PKC-	NULL
.	NULL

Experiments	NULL
were	NULL
performed	NULL
in	NULL
duplicate	NULL
,	NULL
and	NULL
standard	NULL
deviations	NULL
are	NULL
indicated	NULL
by	NULL
error	NULL
bars	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Shown	NULL
are	NULL
results	NULL
from	NULL
three	NULL
different	NULL
experiments	NULL
in	NULL
which	NULL
U937	NULL
HIV-infected	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
3	NULL
«	NULL
B	NULL
cona-luc	NULL
and	NULL
either	NULL
mock	NULL
(	NULL
0	NULL
)	NULL
,	NULL
sense	NULL
(	NULL
SENSE	NULL
)	NULL
,	NULL
or	NULL
antisense	NULL
(	NULL
ANTI-SENSE	NULL
)	NULL
(	NULL
10	NULL
M	NULL
)	NULL
oligonucleotides	NULL
to	NULL
PKC-f	NULL
following	NULL
the	NULL
same	NULL
experimental	NULL
design	NULL
as	NULL
used	NULL
for	NULL
the	NULL
experiments	NULL
represented	NULL
in	NULL
panels	NULL
A	NULL
and	NULL
B	NULL
.	NULL

The	NULL
mean	NULL
for	NULL
the	NULL
three	NULL
experiments	NULL
is	NULL
expressed	NULL
as	NULL
percent	NULL
reduction	NULL
from	NULL
the	NULL
baseline	NULL
activity	NULL
of	NULL
mock-treated	NULL
cells	NULL
.	NULL

Error	NULL
bars	NULL
indicate	NULL
standard	NULL
deviations	NULL
.	NULL

RLU	NULL
,	NULL
relative	NULL
light	NULL
units	NULL
.	NULL

antisense	NULL
oligonucleotides	NULL
to	NULL
PKC-y	NULL
conveyed	NULL
a	NULL
functional	NULL
inhibitory	NULL
effect	NULL
,	NULL
uninfected	NULL
U937	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
a	NULL
xB-luc	NULL
reporter	NULL
gene	NULL
and	NULL
sense	NULL
or	NULL
antisense	NULL
oligonucleotides	NULL
to	NULL
PKC-y	NULL
and	NULL
PKC-£	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
PMA	NULL
stimulation	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
the	NULL
antisense	NULL
oligonucleotides	NULL
to	NULL
PKC-y	NULL
but	NULL
not	NULL
PKC-£	NULL
partially	NULL
inhibited	NULL
the	NULL
NF-kB	NULL
activity	NULL
induced	NULL
by	NULL
PMA	NULL
.	NULL

These	NULL
results	NULL
obtained	NULL
with	NULL
antisense	NULL
oligonucleotides	NULL
indicate	NULL
certain	NULL
specificity	NULL
of	NULL
aPKCs	NULL
such	NULL
as	NULL
PKC-£	NULL
in	NULL
mediating	NULL
HIV-dependent	NULL
activation	NULL
of	NULL
NF-kB	NULL
and	NULL
of	NULL
the	NULL
cPKC	NULL
isoform	NULL
(	NULL
PKC-y	NULL
)	NULL
in	NULL
mediating	NULL
phorbol	NULL
ester-dependent	NULL
NF-kB	NULL
activation	NULL
.	NULL

negative	NULL
dominant	NULL
molecules	NULL
selectively	NULL
interfere	NULL
with	NULL
HIV-induced	NULL
NF-KB	NULL
activity	NULL
.	NULL

Overexpressed	NULL
functional	NULL
inactive	NULL
proteins	NULL
that	NULL
lack	NULL
the	NULL
catalytic	NULL
domain	NULL
of	NULL
an	NULL
enzyme	NULL
compete	NULL
with	NULL
the	NULL
endogenous	NULL
protein	NULL
,	NULL
thus	NULL
decreasing	NULL
its	NULL
function	NULL
,	NULL
and	NULL
behave	NULL
as	NULL
negative	NULL
dominant	NULL
molecules	NULL
.	NULL

A	NULL
mutant	NULL
form	NULL
of	NULL
PKC-£	NULL
has	NULL
been	NULL
previously	NULL
shown	NULL
to	NULL
compete	NULL
with	NULL
and	NULL
inhibit	NULL
the	NULL
effects	NULL
of	NULL
PKC-	NULL
in	NULL
promoting	NULL
mitogenesis	NULL
and	NULL
cell	NULL
transformation	NULL
(	NULL
10	NULL
,	NULL
12	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
to	NULL
confirm	NULL
that	NULL
PKC-£	NULL
is	NULL
selectively	NULL
inhibiting	NULL
the	NULL
HIV	NULL
-induced	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
in	NULL
U937	NULL
cells	NULL
and	NULL
to	NULL
exclude	NULL
a	NULL
nonspecific	NULL
inhibition	NULL
of	NULL
other	NULL
cell	NULL
functions	NULL
by	NULL
oligonucleotide	NULL
administration	NULL
,	NULL
we	NULL
used	NULL
the	NULL
PKC-£	NULL
negative	NULL
dominant	NULL
molecule	NULL
,	NULL
PKC-£	NULL
``	NULL
``	NULL
*	NULL
.	NULL

First	NULL
,	NULL
we	NULL
tested	NULL
whether	NULL
PKC-Z	NULL
``	NULL
*	NULL
selectively	NULL
inhibited	NULL
the	NULL
HIV-induced	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
and	NULL
not	NULL
the	NULL
basal	NULL
or	NULL
inducible	NULL
activity	NULL
of	NULL
other	NULL
transcription	NULL
factors	NULL
.	NULL

Uninfected	NULL
and	NULL
HIV-infected	NULL
U937	NULL
cells	NULL
were	NULL
transiently	NULL
cotransfected	NULL
with	NULL
AP1-lue	NULL
or	NULL
3	NULL
«	NULL
kB-lue	NULL
and	NULL
PKC-L	NULL
``	NULL
*	NULL
.	NULL

Confirming	NULL
the	NULL
data	NULL
obtained	NULL
with	NULL
the	NULL
PKC-L£	NULL
antisense	NULL
oligonucleotides	NULL
,	NULL
PKC-L	NULL
``	NULL
**	NULL
selectively	NULL
inhibited	NULL
the	NULL
HIV-induced	NULL
NF-kB	NULL
activity	NULL
but	NULL
not	NULL
the	NULL
basal	NULL
activity	NULL
of	NULL
an	NULL
AP1-luc	NULL
reporter	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
different	NULL
sets	NULL
of	NULL
experiments	NULL
in	NULL
which	NULL
transfection	NULL
of	NULL
the	NULL
expression	NULL
vector	NULL
did	NULL
not	NULL
interfere	NULL
with	NULL
basal	NULL
activity	NULL
of	NULL
a	NULL
CREB-luc	NULL
reporter	NULL
plasmid	NULL
which	NULL
,	NULL
as	NULL
with	NULL
AP1	NULL
,	NULL
was	NULL
not	NULL
found	NULL
to	NULL
be	NULL
increased	NULL
in	NULL
HIV-infected	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

Because	NULL
transient	NULL
transfection	NULL
results	NULL
in	NULL
protein	NULL
expression	NULL
of	NULL
the	NULL
transfected	NULL
gene	NULL
in	NULL
a	NULL
very	NULL
low	NULL
percentage	NULL
of	NULL
cells	NULL
,	NULL
thus	NULL
limiting	NULL
our	NULL
ability	NULL
to	NULL
detect	NULL
the	NULL
expression	NULL
of	NULL
PKC-C	NULL
``	NULL
``	NULL
,	NULL
and	NULL
to	NULL
control	NULL
for	NULL
possible	NULL
differences	NULL
in	NULL
expression	NULL
levels	NULL
of	NULL
PKC-Z	NULL
between	NULL
uninfected	NULL
and	NULL
HIV-infected	NULL
cells	NULL
,	NULL
the	NULL
CMV	NULL
expression	NULL
vector	NULL
driving	NULL
the	NULL
transcription	NULL
of	NULL
PKC-£	NULL
``	NULL
*	NULL
was	NULL
cloned	NULL
upstream	NULL
of	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
(	NULL
CMV	NULL
-luc	NULL
)	NULL
and	NULL
transfected	NULL
in	NULL
parallel	NULL
with	NULL
a	NULL
3	NULL
kB-luc	NULL
construct	NULL
into	NULL
uninfected	NULL
and	NULL
HIV-infected	NULL
U937	NULL
cells	NULL
.	NULL

While	NULL
increased	NULL
NF-B-dependent	NULL
transcriptional	NULL
activity	NULL
was	NULL
present	NULL
in	NULL
HIV-infected	NULL
cells	NULL
,	NULL
the	NULL
basal	NULL
activities	NULL
of	NULL
the	NULL
CMV	NULL
-luc	NULL
reporter	NULL
genes	NULL
were	NULL
similar	NULL
in	NULL
the	NULL
two	NULL
cell	NULL
lines	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
levels	NULL
of	NULL
expression	NULL
of	NULL
are	NULL
similar	NULL
in	NULL
the	NULL
two	NULL
cell	NULL
groups	NULL
.	NULL

We	NULL
next	NULL
determined	NULL
whether	NULL
other	NULL
stimuli	NULL
that	NULL
result	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
U937	NULL
cells	NULL
,	NULL
such	NULL
as	NULL
PMA	NULL
and	NULL
LPS	NULL
,	NULL
require	NULL
PKC-£	NULL
.	NULL

U937	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
3	NULL
«	NULL
kB-luc	NULL
reporter	NULL
plasmid	NULL
and	NULL
either	NULL
the	NULL
CMV	NULL
expression	NULL
vector	NULL
or	NULL
PKC-T	NULL
``	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
PMA	NULL
or	NULL
LPS	NULL
.	NULL

PMA	NULL
and	NULL
LPS	NULL
,	NULL
respectively	NULL
,	NULL
resulted	NULL
in	NULL
3-	NULL
and	NULL
12-fold	NULL
increases	NULL
in	NULL
NF-kB	NULL
activity	NULL
which	NULL
was	NULL
not	NULL
inhibited	NULL
by	NULL
PKC-£	NULL
``	NULL
``	NULL
``	NULL
*	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
and	NULL
as	NULL
observed	NULL
in	NULL
additional	NULL
experiments	NULL
,	NULL
PKC-	NULL
[	NULL
L	NULL
``	NULL
**	NULL
cotransfection	NULL
was	NULL
associated	NULL
with	NULL
increased	NULL
inducibility	NULL
of	NULL
the	NULL
3	NULL
«	NULL
B-lue	NULL
reporter	NULL
activity	NULL
by	NULL
such	NULL
stimuli	NULL
.	NULL

Altogether	NULL
,	NULL
these	NULL
data	NULL
suggest	NULL
that	NULL
PKC-£	NULL
selectively	NULL
participates	NULL
in	NULL
a	NULL
signal	NULL
transduction	NULL
pathway	NULL
which	NULL
is	NULL
HIV	NULL
induced	NULL
and	NULL
independent	NULL
of	NULL
those	NULL
pathways	NULL
used	NULL
by	NULL
other	NULL
stimuli	NULL
such	NULL
as	NULL
PMA	NULL
or	NULL
LPS	NULL
.	NULL

Cotransfection	NULL
of	NULL
the	NULL
CMV-	NULL
,	NULL
AP1-	NULL
,	NULL
or	NULL
CREB-luc	NULL
reporter	NULL
genes	NULL
and	NULL
PKC-	NULL
``	NULL
into	NULL
U937	NULL
cells	NULL
followed	NULL
by	NULL
PMA	NULL
or	NULL
LPS	NULL
stimulation	NULL
resulted	NULL
in	NULL
a	NULL
three-	NULL
to	NULL
fourfold	NULL
increase	NULL
over	NULL
the	NULL
A	NULL
200	NULL
160	NULL
G3	NULL
-	NULL
120	NULL
3	NULL
é	NULL
80	NULL
40	NULL
0	NULL
a/f	NULL
o	NULL
$	NULL
)	NULL
&	NULL
o/f	NULL
$	NULL
yAXAZE	NULL
cona-luc	NULL
3	NULL
kB	NULL
cona-luc	NULL
B	NULL
100	NULL
80	NULL
es	NULL
Lz	NULL
!	NULL

3	NULL
20	NULL
0	NULL
pmai	NULL
-	NULL
4+	NULL
-	NULL
0	NULL
$	NULL
-	NULL
0	NULL
$	NULL
00	NULL
-	NULL
$	NULL
o-	NULL
+	NULL
sy	NULL
asy	NULL
st	NULL
ast	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

PKC-y	NULL
mediates	NULL
PMA	NULL
but	NULL
not	NULL
dependent	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
HIV-infected	NULL
U937	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
corresponding	NULL
luciferase	NULL
reporter	NULL
gene	NULL
and	NULL
10	NULL
wM	NULL
either	NULL
sense	NULL
(	NULL
s	NULL
)	NULL
or	NULL
antisense	NULL
(	NULL
as	NULL
)	NULL
oligonucleotides	NULL
to	NULL
PKC-y	NULL
(	NULL
7	NULL
)	NULL
or	NULL
PKC-f	NULL
(	NULL
{	NULL
)	NULL
by	NULL
the	NULL
methodology	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Uninfected	NULL
U937	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
an	NULL
NF-kB	NULL
reporter	NULL
plasmid	NULL
and	NULL
oligonucleotides	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
for	NULL
panel	NULL
A	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
PMA	NULL
stimulation	NULL
(	NULL
pma	NULL
)	NULL
(	NULL
20	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
18	NULL
h	NULL
(	NULL
+	NULL
)	NULL
or	NULL
left	NULL
unstimulated	NULL
(	NULL
-	NULL
)	NULL
.	NULL

Error	NULL
bars	NULL
indicate	NULL
standard	NULL
deviations	NULL
.	NULL

RLU	NULL
,	NULL
relative	NULL
light	NULL
units	NULL
.	NULL

228	NULL
FOLGUEIRA	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
80000	NULL
_	NULL
Houy	NULL
2	NULL
«	NULL
]	NULL
(	NULL
C	NULL
~	NULL
3xB-lue	NULL
AP1-luc	NULL
3xB-lue	NULL
AP1-luc	NULL
U937	NULL
NI	NULL
U937	NULL
HIV	NULL
B	NULL
**	NULL
M	NULL
cmuy	NULL
cmyv-pke.-	NULL
;	NULL
mut	NULL
600004	NULL
=	NULL
]	NULL
_I	NULL
-	NULL
400004	NULL
CC	NULL
200004	NULL
3xB-luc	NULL
CREB-luc	NULL
3xB-luc	NULL
CREB-luc	NULL
U937	NULL
NI	NULL
U937	NULL
HIV	NULL
160	NULL
C	NULL
120	NULL
G	NULL
2	NULL
.	NULL

so	NULL
a	NULL
P=	NULL
C	NULL
U937	NULL
Ni	NULL
-	NULL
Us37	NULL
HIV	NULL
U937	NULL
Ni	NULL
-	NULL
U937	NULL
HIV	NULL
xB-luc	NULL
CMV-luc	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

The	NULL
negative	NULL
dominant	NULL
mutant	NULL
of	NULL
PKC-f	NULL
decreases	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
induced	NULL
by	NULL
HIV	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Uninfected	NULL
(	NULL
Nl	NULL
)	NULL
or	NULL
HIV-infected	NULL
(	NULL
HIV	NULL
)	NULL
U937	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
a	NULL
3	NULL
xB-luc	NULL
or	NULL
an	NULL
AP1-lue	NULL
reporter	NULL
gene	NULL
and	NULL
the	NULL
CMV	NULL
expression	NULL
vector	NULL
(	NULL
CMV	NULL
)	NULL
or	NULL
the	NULL
CMV	NULL
promoter	NULL
(	NULL
CMV-PKC-	NULL
{	NULL
*	NULL
``	NULL
)	NULL
.	NULL

Experiments	NULL
were	NULL
performed	NULL
in	NULL
duplicate	NULL
,	NULL
and	NULL
the	NULL
standard	NULL
deviation	NULL
is	NULL
represented	NULL
above	NULL
each	NULL
bar	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Same	NULL
as	NULL
for	NULL
panel	NULL
A	NULL
,	NULL
except	NULL
that	NULL
a	NULL
CREB-luc	NULL
reporter	NULL
gene	NULL
was	NULL
used	NULL
instead	NULL
of	NULL
an	NULL
AP1-luc	NULL
reporter	NULL
gene	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Uninfected	NULL
(	NULL
NL	NULL
)	NULL
or	NULL
HIV-infected	NULL
(	NULL
HIV	NULL
)	NULL
U937	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
either	NULL
3	NULL
«	NULL
B	NULL
cona-luc	NULL
(	NULL
«	NULL
B-luc	NULL
)	NULL
or	NULL
the	NULL
CMV	NULL
expression	NULL
vector	NULL
used	NULL
for	NULL
the	NULL
experiments	NULL
represented	NULL
in	NULL
panels	NULL
A	NULL
and	NULL
B	NULL
but	NULL
cloned	NULL
upstream	NULL
of	NULL
the	NULL
luciferase	NULL
gene	NULL
(	NULL
CMV-luc	NULL
)	NULL
.	NULL

RLU	NULL
,	NULL
relative	NULL
light	NULL
units	NULL
.	NULL

basal	NULL
activity	NULL
of	NULL
these	NULL
reporter	NULL
genes	NULL
which	NULL
was	NULL
not	NULL
modified	NULL
by	NULL
PKC-	NULL
(	NULL
``	NULL
**	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Previous	NULL
studies	NULL
by	NULL
our	NULL
group	NULL
demonstrated	NULL
that	NULL
HIV	NULL
infection	NULL
upregulates	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
in	NULL
U937	NULL
cells	NULL
in	NULL
a	NULL
manner	NULL
independent	NULL
of	NULL
PMA-independent	NULL
pathways	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
cPKC	NULL
)	NULL
and	NULL
J.	NULL
ViroL	NULL
.	NULL

that	NULL
PMA	NULL
and	NULL
HIV	NULL
synergize	NULL
to	NULL
activate	NULL
NF-kB	NULL
(	NULL
46	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
PKC-£	NULL
participates	NULL
in	NULL
the	NULL
HIV-	NULL
but	NULL
not	NULL
the	NULL
PMA-induced	NULL
pathway	NULL
and	NULL
to	NULL
test	NULL
whether	NULL
the	NULL
previously	NULL
observed	NULL
synergy	NULL
between	NULL
PMA	NULL
and	NULL
HIV	NULL
is	NULL
reversed	NULL
by	NULL
the	NULL
mutant	NULL
form	NULL
of	NULL
PKC-	NULL
,	NULL
we	NULL
performed	NULL
the	NULL
following	NULL
experiments	NULL
.	NULL

Uninfected	NULL
and	NULL
HIV-infected	NULL
U937	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
NF-	NULL
«	NULL
B-dependent	NULL
reporter	NULL
gene	NULL
and	NULL
the	NULL
PKC-£	NULL
``	NULL
**	NULL
expression	NULL
vector	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
PMA	NULL
stimulation	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
previous	NULL
experiments	NULL
,	NULL
the	NULL
HIV	NULL
-induced	NULL
but	NULL
not	NULL
the	NULL
basal	NULL
or	NULL
PMA-induced	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
in	NULL
uninfected	NULL
cells	NULL
was	NULL
reduced	NULL
by	NULL
PKC-£	NULL
``	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

PMA	NULL
treatment	NULL
of	NULL
HIV-infected	NULL
U937	NULL
2	NULL
1M	NULL
0	NULL
A	NULL
ASPMA	NULL
OLPps	NULL
``	NULL
B	NULL
Lad	NULL
3	NULL
100	NULL
1	NULL
Pel	NULL
(	NULL
3	NULL
0	NULL
u	NULL
CMyv-mcmy	NULL
emv-pkc.gmut	NULL
``	NULL
C	NULL
wi	NULL
-	NULL
1000	NULL
1	NULL
fest	NULL
ted	NULL
7	NULL
0	NULL
P	NULL
0	NULL
PMA	NULL
G	NULL
PMA	NULL
U937	NULL
NI	NULL
U937	NULL
HIV	NULL
FIG	NULL
.	NULL

6.	NULL
blocks	NULL
HIV-	NULL
but	NULL
not	NULL
PMA-	NULL
or	NULL
LPS-induced	NULL
NF-B	NULL
activation	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Uninfected	NULL
U937	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
3	NULL
xB	NULL
cona-luc	NULL
and	NULL
either	NULL
the	NULL
CMV	NULL
expression	NULL
vector	NULL
alone	NULL
(	NULL
CMV-	NULL
)	NULL
or	NULL
the	NULL
CMV	NULL
expression	NULL
vector	NULL
driving	NULL
the	NULL
PKC-	NULL
mutant	NULL
(	NULL
CMV-PKC-	NULL
{	NULL
``	NULL
``	NULL
)	NULL
.	NULL

Following	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
left	NULL
unstimulated	NULL
(	NULL
g	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
PMA	NULL
(	NULL
20	NULL
ng/ml	NULL
)	NULL
or	NULL
LPS	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
for	NULL
18	NULL
h.	NULL
The	NULL
standard	NULL
deviation	NULL
is	NULL
represented	NULL
above	NULL
each	NULL
bar	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Same	NULL
experimental	NULL
design	NULL
as	NULL
for	NULL
panel	NULL
A	NULL
,	NULL
except	NULL
that	NULL
uninfected	NULL
(	NULL
NT	NULL
)	NULL
and	NULL
HIV-infected	NULL
(	NULL
HIV	NULL
)	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
3	NULL
kB	NULL
cona-luc	NULL
and	NULL
with	NULL
the	NULL
CMV	NULL
expression	NULL
vector	NULL
(	NULL
CMV	NULL
)	NULL
or	NULL
the	NULL
CMV	NULL
expression	NULL
vector	NULL
driving	NULL
the	NULL
PKC-	NULL
{	NULL
``	NULL
``	NULL
*	NULL
gene	NULL
(	NULL
CMV-PKC-	NULL
{	NULL
**	NULL
)	NULL
and	NULL
either	NULL
left	NULL
unstimulated	NULL
(	NULL
g	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
PMA	NULL
(	NULL
20	NULL
ng/ml	NULL
)	NULL
.	NULL

RLU	NULL
,	NULL
relative	NULL
light	NULL
units	NULL
.	NULL

voL	NULL
.	NULL

70	NULL
,	NULL
1996	NULL
IJ	NULL
mock	NULL
§§	NULL
sense	NULL
anti-sense	NULL
p24	NULL
ng/mi	NULL
0	NULL
G	NULL
day	NULL
14	NULL
day	NULL
21	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

Antisense	NULL
oligonucleotides	NULL
to	NULL
PKC-f	NULL
decrease	NULL
HIV	NULL
replication	NULL
in	NULL
HIV-infected	NULL
human	NULL
macrophages	NULL
.	NULL

Human-derived	NULL
macrophages	NULL
were	NULL
infected	NULL
with	NULL
the	NULL
HIV	NULL
strain	NULL
SF	NULL
;	NULL
4	NULL
,	NULL
and	NULL
treated	NULL
twice	NULL
weekly	NULL
with	NULL
either	NULL
mock	NULL
,	NULL
sense	NULL
,	NULL
or	NULL
antisense	NULL
oligonucleotides	NULL
(	NULL
5	NULL
M	NULL
)	NULL
.	NULL

Supernatants	NULL
were	NULL
harvested	NULL
at	NULL
days	NULL
14	NULL
and	NULL
21	NULL
and	NULL
assayed	NULL
for	NULL
p24	NULL
content	NULL
.	NULL

Experiments	NULL
were	NULL
done	NULL
in	NULL
duplicate	NULL
wells	NULL
,	NULL
and	NULL
the	NULL
standard	NULL
deviation	NULL
is	NULL
indicated	NULL
by	NULL
a	NULL
line	NULL
on	NULL
top	NULL
of	NULL
each	NULL
bar	NULL
.	NULL

cells	NULL
synergistically	NULL
increased	NULL
the	NULL
HIV-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
,	NULL
and	NULL
the	NULL
effect	NULL
was	NULL
decreased	NULL
by	NULL
cotransfection	NULL
of	NULL
the	NULL
mutant	NULL
form	NULL
of	NULL
PKC-£	NULL
.	NULL

Overall	NULL
,	NULL
these	NULL
experiments	NULL
confirm	NULL
that	NULL
HIV	NULL
infection	NULL
results	NULL
in	NULL
the	NULL
upregulation	NULL
of	NULL
a	NULL
signal	NULL
transduction	NULL
pathway	NULL
in	NULL
which	NULL
PKC-£	NULL
is	NULL
one	NULL
of	NULL
the	NULL
components	NULL
and	NULL
that	NULL
another	NULL
pathway	NULL
(	NULL
s	NULL
)	NULL
or	NULL
other	NULL
mechanisms	NULL
that	NULL
regulate	NULL
NF-kB	NULL
activation	NULL
,	NULL
such	NULL
as	NULL
those	NULL
initiated	NULL
by	NULL
PMA	NULL
,	NULL
can	NULL
synergize	NULL
with	NULL
or	NULL
complement	NULL
the	NULL
HIV-PKC-£-dependent	NULL
pathway	NULL
.	NULL

PKC-£	NULL
antisense	NULL
oligonucleotides	NULL
reduce	NULL
HIV	NULL
replication	NULL
in	NULL
HIV-infected	NULL
MDM	NULL
.	NULL

Having	NULL
identified	NULL
a	NULL
specific	NULL
second	NULL
messenger	NULL
of	NULL
a	NULL
signal	NULL
transduction	NULL
pathway	NULL
that	NULL
appears	NULL
to	NULL
be	NULL
selectively	NULL
used	NULL
by	NULL
HIV	NULL
infection	NULL
in	NULL
monocytic	NULL
cells	NULL
to	NULL
upregu-late	NULL
NF-kB	NULL
,	NULL
we	NULL
tested	NULL
whether	NULL
inhibition	NULL
of	NULL
PKC-£	NULL
would	NULL
lead	NULL
to	NULL
decreased	NULL
viral	NULL
replication	NULL
and	NULL
thus	NULL
establish	NULL
a	NULL
correlation	NULL
between	NULL
NF-kB	NULL
activation	NULL
and	NULL
persistent	NULL
viral	NULL
replication	NULL
.	NULL

To	NULL
test	NULL
this	NULL
hypothesis	NULL
,	NULL
MDM	NULL
infected	NULL
with	NULL
a	NULL
monocytotropic	NULL
strain	NULL
of	NULL
HIV	NULL
were	NULL
used	NULL
as	NULL
a	NULL
more	NULL
relevant	NULL
model	NULL
of	NULL
persistent	NULL
viral	NULL
replication	NULL
.	NULL

HIV-infected	NULL
MDM	NULL
were	NULL
treated	NULL
with	NULL
sense	NULL
or	NULL
antisense	NULL
oligonucleotides	NULL
twice	NULL
weekly	NULL
at	NULL
the	NULL
time	NULL
of	NULL
cell	NULL
passage	NULL
,	NULL
and	NULL
culture	NULL
supernatant	NULL
was	NULL
then	NULL
analyzed	NULL
for	NULL
p24	NULL
content	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
HIV	NULL
replication	NULL
was	NULL
reduced	NULL
approximately	NULL
50	NULL
to	NULL
60	NULL
%	NULL
by	NULL
the	NULL
antisense	NULL
oligonucleotide	NULL
to	NULL
PKC-	NULL
at	NULL
both	NULL
14	NULL
and	NULL
21	NULL
days	NULL
postinfection	NULL
.	NULL

Sense	NULL
oligonucleotide	NULL
also	NULL
interfered	NULL
with	NULL
viral	NULL
replication	NULL
,	NULL
albeit	NULL
to	NULL
a	NULL
lesser	NULL
degree	NULL
,	NULL
suggesting	NULL
a	NULL
nonspecific	NULL
effect	NULL
of	NULL
oligonucleotides	NULL
on	NULL
viral	NULL
replication	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
MDM	NULL
were	NULL
monitored	NULL
morpho-logically	NULL
with	NULL
every	NULL
culture	NULL
passage	NULL
and	NULL
on	NULL
day	NULL
21	NULL
analyzed	NULL
for	NULL
cell	NULL
viability	NULL
by	NULL
use	NULL
of	NULL
a	NULL
modified	NULL
trypan	NULL
blue	NULL
analysis	NULL
.	NULL

Although	NULL
cell	NULL
viabilities	NULL
were	NULL
similar	NULL
among	NULL
the	NULL
three	NULL
treatment	NULL
groups	NULL
(	NULL
mock	NULL
,	NULL
sense	NULL
,	NULL
and	NULL
antisense	NULL
)	NULL
,	NULL
the	NULL
decreased	NULL
p24	NULL
levels	NULL
correlated	NULL
,	NULL
in	NULL
a	NULL
blinded	NULL
fashion	NULL
,	NULL
with	NULL
decreased	NULL
HIV	NULL
-induced	NULL
morphological	NULL
changes	NULL
(	NULL
cell	NULL
enlargement	NULL
and	NULL
vacuolization	NULL
of	NULL
the	NULL
apparent	NULL
infected	NULL
cells	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Taking	NULL
into	NULL
account	NULL
the	NULL
potential	NULL
limitations	NULL
of	NULL
oligonucleotides	NULL
in	NULL
inhibiting	NULL
HIV	NULL
replication	NULL
,	NULL
these	NULL
preliminary	NULL
studies	NULL
with	NULL
MDM	NULL
imply	NULL
that	NULL
PKC-£	NULL
is	NULL
a	NULL
host	NULL
cell	NULL
protein	NULL
that	NULL
participates	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
viral	NULL
replication	NULL
in	NULL
MDM	NULL
.	NULL

Future	NULL
studies	NULL
will	NULL
need	NULL
to	NULL
address	NULL
the	NULL
impact	NULL
of	NULL
inhibiting	NULL
this	NULL
PKC	NULL
isoenzyme	NULL
on	NULL
macrophage	NULL
function	NULL
and	NULL
whether	NULL
PKC-£	NULL
selectively	NULL
interferes	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
HIV	NULL
infection	NULL
and	NULL
other	NULL
physiological	NULL
stimuli	NULL
.	NULL

PKC-f	NULL
MEDIATES	NULL
NF-	NULL
«	NULL
B	NULL
ACTIVATION	NULL
IN	NULL
MONOCYTES	NULL
229	NULL
DISCUSSION	NULL
In	NULL
search	NULL
of	NULL
cellular	NULL
signal	NULL
transduction	NULL
pathways	NULL
leading	NULL
to	NULL
NF-kB	NULL
activation	NULL
in	NULL
HIV-infected	NULL
cells	NULL
,	NULL
our	NULL
studies	NULL
indicate	NULL
that	NULL
PKC-£	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
aPKC	NULL
isoform	NULL
family	NULL
,	NULL
is	NULL
a	NULL
second	NULL
messenger	NULL
involved	NULL
in	NULL
this	NULL
virus-host	NULL
cell	NULL
interaction	NULL
.	NULL

Interruption	NULL
of	NULL
PKC-£	NULL
function	NULL
by	NULL
using	NULL
different	NULL
genetic	NULL
approaches	NULL
in	NULL
monocytic	NULL
cell	NULL
lines	NULL
and	NULL
human	NULL
macrophages	NULL
leads	NULL
to	NULL
decreased	NULL
HIV-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
and	NULL
viral	NULL
replication	NULL
.	NULL

Activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
different	NULL
viruses	NULL
suggests	NULL
that	NULL
this	NULL
type	NULL
of	NULL
virus-host	NULL
cell	NULL
interaction	NULL
may	NULL
be	NULL
important	NULL
for	NULL
effective	NULL
viral	NULL
replication	NULL
.	NULL

For	NULL
HIV	NULL
,	NULL
NF-kB	NULL
has	NULL
been	NULL
clearly	NULL
established	NULL
as	NULL
a	NULL
key	NULL
transcription	NULL
factor	NULL
in	NULL
modulating	NULL
the	NULL
HIV	NULL
enhancer-promoter	NULL
region	NULL
(	NULL
41	NULL
,	NULL
47	NULL
)	NULL
,	NULL
regulating	NULL
not	NULL
only	NULL
reactivation	NULL
from	NULL
latency	NULL
but	NULL
also	NULL
viral	NULL
persistence	NULL
(	NULL
1	NULL
,	NULL
5	NULL
,	NULL
28	NULL
,	NULL
30	NULL
,	NULL
31	NULL
,	NULL
37	NULL
,	NULL
45	NULL
,	NULL
47	NULL
,	NULL
50	NULL
,	NULL
53	NULL
,	NULL
56	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
macrophage	NULL
is	NULL
a	NULL
reservoir	NULL
of	NULL
persistent	NULL
viral	NULL
replication	NULL
in	NULL
infected	NULL
individuals	NULL
(	NULL
19	NULL
,	NULL
20	NULL
)	NULL
and	NULL
since	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
infection	NULL
with	NULL
monocytotropic	NULL
viruses	NULL
increases	NULL
NF-KB	NULL
activation	NULL
in	NULL
human	NULL
macrophages	NULL
(	NULL
38	NULL
)	NULL
,	NULL
we	NULL
have	NULL
started	NULL
to	NULL
dissect	NULL
potential	NULL
signal	NULL
transduction	NULL
pathways	NULL
that	NULL
regulate	NULL
NF-B	NULL
activation	NULL
in	NULL
infected	NULL
cells	NULL
.	NULL

Although	NULL
little	NULL
information	NULL
as	NULL
to	NULL
what	NULL
signal	NULL
transduction	NULL
pathways	NULL
are	NULL
functional	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
monocytic	NULL
lineage	NULL
is	NULL
available	NULL
,	NULL
our	NULL
previous	NULL
work	NULL
indicated	NULL
that	NULL
PKC	NULL
isoenzymes	NULL
regulated	NULL
by	NULL
phorbol	NULL
esters	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
cPKC	NULL
isoforms	NULL
)	NULL
were	NULL
functional	NULL
in	NULL
mediating	NULL
NF-B	NULL
activation	NULL
in	NULL
monocytic	NULL
cells	NULL
(	NULL
46	NULL
)	NULL
.	NULL

However	NULL
,	NULL
persistent	NULL
HIV	NULL
infection	NULL
of	NULL
those	NULL
cells	NULL
resulted	NULL
in	NULL
NF-kB	NULL
activation	NULL
through	NULL
other	NULL
PKC	NULL
isoenzymes	NULL
and/or	NULL
PKC-independent	NULL
pathways	NULL
.	NULL

To	NULL
explore	NULL
the	NULL
first	NULL
option	NULL
,	NULL
we	NULL
have	NULL
first	NULL
focused	NULL
on	NULL
a	NULL
PKC	NULL
isoenzyme	NULL
that	NULL
has	NULL
been	NULL
classified	NULL
as	NULL
atypical	NULL
(	NULL
differing	NULL
from	NULL
cPKC	NULL
by	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
Ca**-	NULL
and	NULL
diacylglycerol-responsive	NULL
elements	NULL
)	NULL
and	NULL
shown	NULL
to	NULL
mediate	NULL
NF-kB	NULL
activation	NULL
in	NULL
murine	NULL
cells	NULL
and	NULL
oocytes	NULL
(	NULL
10	NULL
,	NULL
14	NULL
)	NULL
.	NULL

The	NULL
mechanisms	NULL
by	NULL
which	NULL
PKC-£	NULL
results	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
are	NULL
the	NULL
subject	NULL
of	NULL
active	NULL
study	NULL
.	NULL

This	NULL
transcription	NULL
factor	NULL
is	NULL
regulated	NULL
at	NULL
multiple	NULL
levels	NULL
and	NULL
by	NULL
a	NULL
variety	NULL
of	NULL
inhibitory	NULL
proteins	NULL
(	NULL
reviewed	NULL
in	NULL
references	NULL
3	NULL
and	NULL
35	NULL
)	NULL
.	NULL

One	NULL
such	NULL
inhibitor	NULL
,	NULL
IxBa	NULL
(	NULL
11	NULL
)	NULL
,	NULL
is	NULL
a	NULL
target	NULL
of	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
following	NULL
activation	NULL
of	NULL
yet-ill-defined	NULL
signal	NULL
transduction	NULL
pathways	NULL
by	NULL
multiple	NULL
extracellular	NULL
stimuli	NULL
.	NULL

Recent	NULL
studies	NULL
indicate	NULL
that	NULL
PKC-£	NULL
binds	NULL
a	NULL
kinase	NULL
that	NULL
in	NULL
vitro	NULL
leads	NULL
to	NULL
the	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
,	NULL
implicating	NULL
this	NULL
inhibitor	NULL
as	NULL
a	NULL
potential	NULL
target	NULL
of	NULL
PKC-	NULL
{	NULL
-dependent	NULL
steps	NULL
resulting	NULL
in	NULL
NF-kB	NULL
activation	NULL
in	NULL
vivo	NULL
.	NULL

Persistent	NULL
HIV	NULL
replication	NULL
in	NULL
human	NULL
monocytic	NULL
cells	NULL
and	NULL
macrophages	NULL
is	NULL
associated	NULL
with	NULL
increased	NULL
turnover	NULL
of	NULL
IxBa	NULL
,	NULL
resulting	NULL
in	NULL
levels	NULL
constitutively	NULL
decreased	NULL
from	NULL
those	NULL
present	NULL
in	NULL
uninfected	NULL
controls	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Although	NULL
studies	NULL
to	NULL
examine	NULL
the	NULL
phosphorylation	NULL
characteristics	NULL
of	NULL
IxBa	NULL
in	NULL
infected	NULL
cells	NULL
are	NULL
under	NULL
way	NULL
,	NULL
our	NULL
preliminary	NULL
data	NULL
indicate	NULL
that	NULL
IxBa	NULL
is	NULL
hyper-phosphorylated	NULL
following	NULL
HIV	NULL
infection	NULL
,	NULL
probably	NULL
rendering	NULL
it	NULL
more	NULL
susceptible	NULL
to	NULL
degradation	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
recent	NULL
studies	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
plausible	NULL
that	NULL
pathways	NULL
lead	NULL
to	NULL
the	NULL
phosphorylation	NULL
and	NULL
subsequent	NULL
degradation	NULL
of	NULL
IxBa	NULL
in	NULL
HIV-infected	NULL
cells	NULL
,	NULL
resulting	NULL
in	NULL
persistent	NULL
NF-kB	NULL
nuclear	NULL
translocation	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Further	NULL
studies	NULL
are	NULL
required	NULL
to	NULL
evaluate	NULL
whether	NULL
PKC-£	NULL
itself	NULL
or	NULL
associated	NULL
kinases	NULL
are	NULL
involved	NULL
in	NULL
modifying	NULL
IxBa	NULL
in	NULL
HIV-infected	NULL
cells	NULL
.	NULL

Moreover	NULL
,	NULL
other	NULL
NF-kB	NULL
inhibitory	NULL
molecules	NULL
,	NULL
such	NULL
as	NULL
IxBB	NULL
,	NULL
have	NULL
been	NULL
recently	NULL
cloned	NULL
(	NULL
58	NULL
)	NULL
and	NULL
shown	NULL
to	NULL
be	NULL
regulated	NULL
by	NULL
posttranslational	NULL
modifications	NULL
similar	NULL
to	NULL
those	NULL
regulating	NULL
IxBa	NULL
;	NULL
thus	NULL
,	NULL
future	NULL
investigation	NULL
should	NULL
address	NULL
whether	NULL
NF-KB	NULL
inhibitor	NULL
molecules	NULL
other	NULL
than	NULL
IxBa	NULL
are	NULL
targets	NULL
of	NULL
HIV	NULL
and/or	NULL
PKC-£	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
HIV	NULL
infection	NULL
,	NULL
but	NULL
not	NULL
phorbol	NULL
esters	NULL
or	NULL
LPS	NULL
,	NULL
activates	NULL
NF-	NULL
«	NULL
xB	NULL
through	NULL
this	NULL
kinase	NULL
suggests	NULL
certain	NULL
specificity	NULL
for	NULL
the	NULL
HIV-induced	NULL
signal	NULL
transduction	NULL
pathways	NULL
in	NULL
monocytic	NULL
cell	NULL
lines	NULL
and	NULL
suggests	NULL
that	NULL
this	NULL
kinase	NULL
must	NULL
be	NULL
upstream	NULL
230	NULL
FOLGUEIRA	NULL
ET	NULL
AL	NULL
.	NULL

of	NULL
the	NULL
converging	NULL
common	NULL
pathway	NULL
that	NULL
regulates	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
multiple	NULL
unrelated	NULL
stimuli	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
function	NULL
of	NULL
this	NULL
kinase	NULL
may	NULL
be	NULL
cell	NULL
specific	NULL
.	NULL

PKC-£	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
mediate	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
mouse	NULL
fibroblasts	NULL
and	NULL
oocytes	NULL
in	NULL
response	NULL
to	NULL
extracellular	NULL
stimuli	NULL
such	NULL
as	NULL
phospholipase	NULL
C	NULL
(	NULL
10	NULL
,	NULL
14	NULL
)	NULL
,	NULL
but	NULL
not	NULL
in	NULL
T	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
different	NULL
modes	NULL
of	NULL
T-cell	NULL
activation	NULL
(	NULL
21	NULL
,	NULL
23	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
interruption	NULL
of	NULL
PKC-£	NULL
in	NULL
other	NULL
cell	NULL
systems	NULL
has	NULL
not	NULL
been	NULL
associated	NULL
with	NULL
disruption	NULL
and	NULL
other	NULL
cell	NULL
functions	NULL
(	NULL
10	NULL
,	NULL
14	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
suggest	NULL
that	NULL
disruption	NULL
of	NULL
PKC-	NULL
{	NULL
in	NULL
monocytes	NULL
could	NULL
potentially	NULL
interfere	NULL
with	NULL
HIV-induced	NULL
NF-kB	NULL
activation	NULL
and	NULL
therefore	NULL
possibly	NULL
interfere	NULL
with	NULL
viral	NULL
persistence	NULL
without	NULL
altering	NULL
other	NULL
physiological	NULL
functions	NULL
of	NULL
the	NULL
cell	NULL
and	NULL
thus	NULL
target	NULL
this	NULL
molecule	NULL
for	NULL
future	NULL
therapeutical	NULL
intervention	NULL
.	NULL

The	NULL
exact	NULL
location	NULL
of	NULL
PKC-£	NULL
within	NULL
known	NULL
signal	NULL
transduction	NULL
pathways	NULL
is	NULL
being	NULL
studied	NULL
.	NULL

Recent	NULL
data	NULL
point	NULL
towards	NULL
an	NULL
association	NULL
of	NULL
this	NULL
kinase	NULL
with	NULL
p21	NULL
``	NULL
(	NULL
12	NULL
)	NULL
.	NULL

This	NULL
relevant	NULL
proto-oncogene	NULL
is	NULL
critical	NULL
in	NULL
mediating	NULL
signal	NULL
transduction	NULL
signals	NULL
from	NULL
a	NULL
variety	NULL
of	NULL
growth	NULL
factor	NULL
receptors	NULL
although	NULL
dispensable	NULL
for	NULL
some	NULL
cytokine	NULL
receptor-initiated	NULL
signals	NULL
(	NULL
49	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
exact	NULL
relationship	NULL
between	NULL
these	NULL
two	NULL
second	NULL
messengers	NULL
is	NULL
unknown	NULL
,	NULL
PKC-£	NULL
appears	NULL
to	NULL
be	NULL
downstream	NULL
of	NULL
p21	NULL
``	NULL
but	NULL
unrelated	NULL
to	NULL
the	NULL
other	NULL
well-characterized	NULL
downstream	NULL
target	NULL
of	NULL
ras	NULL
,	NULL
raf-1	NULL
kinase	NULL
(	NULL
12	NULL
)	NULL
.	NULL

PI-3	NULL
kinase	NULL
has	NULL
been	NULL
recently	NULL
shown	NULL
to	NULL
be	NULL
another	NULL
downstream	NULL
second	NULL
messenger	NULL
of	NULL
p21	NULL
``	NULL
(	NULL
49	NULL
)	NULL
and	NULL
to	NULL
activate	NULL
PKC-£	NULL
in	NULL
vitro	NULL
(	NULL
42	NULL
,	NULL
59	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
PKC-£	NULL
and	NULL
ras	NULL
are	NULL
physically	NULL
associated	NULL
following	NULL
cell	NULL
activation	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Altogether	NULL
,	NULL
this	NULL
indicates	NULL
that	NULL
p21	NULL
'	NULL
``	NULL
``	NULL
may	NULL
bifurcate	NULL
its	NULL
signalling	NULL
via	NULL
the	NULL
raf-mitogen-activated	NULL
protein	NULL
kinase	NULL
or	NULL
the	NULL
PI-3	NULL
kinase-PKC-£	NULL
pathway	NULL
.	NULL

More	NULL
studies	NULL
are	NULL
needed	NULL
to	NULL
define	NULL
whether	NULL
PKC-£	NULL
can	NULL
be	NULL
activated	NULL
via	NULL
a	NULL
p21'®-independent	NULL
pathway	NULL
as	NULL
has	NULL
been	NULL
suggested	NULL
recently	NULL
for	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
40	NULL
)	NULL
.	NULL

How	NULL
this	NULL
general	NULL
organization	NULL
scheme	NULL
of	NULL
signal	NULL
transduction	NULL
pathways	NULL
fits	NULL
with	NULL
the	NULL
HIV-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
human	NULL
macrophages	NULL
is	NULL
unknown	NULL
.	NULL

If	NULL
PKC-£	NULL
is	NULL
being	NULL
activated	NULL
by	NULL
p21	NULL
``	NULL
via	NULL
PI-3	NULL
kinase	NULL
,	NULL
it	NULL
is	NULL
plausible	NULL
that	NULL
specific	NULL
inhibitors	NULL
of	NULL
PI-3	NULL
kinase	NULL
,	NULL
such	NULL
as	NULL
wortmannin	NULL
,	NULL
should	NULL
selectively	NULL
interfere	NULL
with	NULL
the	NULL
HIV-induced	NULL
NF-KB	NULL
activation	NULL
in	NULL
these	NULL
cells	NULL
and	NULL
thus	NULL
bypass	NULL
our	NULL
current	NULL
limitation	NULL
of	NULL
lacking	NULL
specific	NULL
pharmacological	NULL
inhibitors	NULL
of	NULL
this	NULL
PKC	NULL
isoenzyme	NULL
.	NULL

A	NULL
new	NULL
PKC	NULL
isoform	NULL
with	NULL
all	NULL
the	NULL
characteristics	NULL
ascribed	NULL
to	NULL
PKC-f	NULL
has	NULL
been	NULL
recently	NULL
cloned	NULL
(	NULL
52	NULL
)	NULL
.	NULL

This	NULL
new	NULL
isoenzyme	NULL
(	NULL
PKC-1	NULL
)	NULL
,	NULL
whose	NULL
function	NULL
remains	NULL
unknown	NULL
,	NULL
has	NULL
an	NULL
extremely	NULL
high	NULL
degree	NULL
of	NULL
homology	NULL
(	NULL
up	NULL
to	NULL
84	NULL
%	NULL
in	NULL
the	NULL
catalytic	NULL
domain	NULL
and	NULL
carboxy-terminus	NULL
region	NULL
)	NULL
to	NULL
the	NULL
better-characterized	NULL
PKC-£	NULL
.	NULL

Because	NULL
many	NULL
of	NULL
the	NULL
reagents	NULL
utilized	NULL
to	NULL
study	NULL
PKC-	NULL
{	NULL
(	NULL
commercial	NULL
antibodies	NULL
,	NULL
which	NULL
are	NULL
directed	NULL
to	NULL
the	NULL
C	NULL
terminus	NULL
,	NULL
and	NULL
dominant	NULL
negative	NULL
molecules	NULL
containing	NULL
mutations	NULL
in	NULL
the	NULL
catalytic	NULL
domain	NULL
)	NULL
may	NULL
potentially	NULL
cross-react	NULL
with	NULL
PKC-	NULL
,	NULL
future	NULL
studies	NULL
addressing	NULL
the	NULL
role	NULL
of	NULL
aPKC-£	NULL
should	NULL
attempt	NULL
to	NULL
determine	NULL
the	NULL
specificity	NULL
of	NULL
these	NULL
isoforms	NULL
in	NULL
the	NULL
different	NULL
models	NULL
tested	NULL
thus	NULL
far	NULL
.	NULL

Understanding	NULL
the	NULL
molecular	NULL
mechanisms	NULL
regulating	NULL
the	NULL
interaction	NULL
between	NULL
HIV	NULL
and	NULL
host	NULL
cell	NULL
proteins	NULL
that	NULL
favor	NULL
effective	NULL
viral	NULL
replication	NULL
and	NULL
that	NULL
mediate	NULL
many	NULL
of	NULL
the	NULL
HIV-induced	NULL
effects	NULL
on	NULL
the	NULL
infected	NULL
cell	NULL
is	NULL
essential	NULL
to	NULL
advance	NULL
our	NULL
knowledge	NULL
of	NULL
HIV	NULL
pathogenesis	NULL
.	NULL

Systematic	NULL
dissection	NULL
of	NULL
signal	NULL
transduction	NULL
pathways	NULL
upregulated	NULL
by	NULL
HIV	NULL
to	NULL
result	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
transcription	NULL
factors	NULL
that	NULL
are	NULL
essential	NULL
for	NULL
viral	NULL
replication	NULL
,	NULL
such	NULL
as	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
should	NULL
identify	NULL
potential	NULL
targets	NULL
for	NULL
therapeutical	NULL
intervention	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Alcami	NULL
,	NULL
J.	NULL
,	NULL
T.	NULL
Lain	NULL
de	NULL
Lera	NULL
,	NULL
L.	NULL
Folgueira	NULL
,	NULL
M.-A	NULL
.	NULL

Pedraza	NULL
,	NULL
J.-M.	NULL
Jacqué	NULL
,	NULL
F.	NULL
Bachelerie	NULL
,	NULL
A.	NULL
R.	NULL
Noriega	NULL
,	NULL
R.	NULL
T.	NULL
Hay	NULL
,	NULL
D.	NULL
Harrich	NULL
,	NULL
R.	NULL
B.	NULL
Gaynor	NULL
,	NULL
J.-L.	NULL
Virelizier	NULL
,	NULL
and	NULL
F.	NULL
Arenzana-Seisdedos	NULL
.	NULL

1995	NULL
.	NULL

Absolute	NULL
dependence	NULL
on	NULL
«	NULL
B	NULL
responsive	NULL
elements	NULL
for	NULL
initiation	NULL
and	NULL
tat-mediated	NULL
amplification	NULL
of	NULL
HIV	NULL
transcription	NULL
in	NULL
blood	NULL
CD4	NULL
T	NULL
lymphocytes	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14:1552-1560	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

J.	NULL
ViroL	NULL
.	NULL

.	NULL

Bachelerie	NULL
,	NULL
F.	NULL
,	NULL
J.	NULL
Alcami	NULL
,	NULL
F.	NULL
Arenzana-Seisdedos	NULL
,	NULL
and	NULL
J.-L.	NULL
Virelizier	NULL
.	NULL

1991	NULL
.	NULL

HIV	NULL
enhancer	NULL
activity	NULL
perpetuated	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
on	NULL
infection	NULL
of	NULL
monocytes	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
350:709-712.	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
T.	NULL
Henkel	NULL
.	NULL

1994	NULL
.	NULL

Function	NULL
and	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12:141-179.	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
S.	NULL
M.	NULL
Ruben	NULL
,	NULL
R.	NULL
I.	NULL
Scheinman	NULL
,	NULL
S.	NULL
Haskill	NULL
,	NULL
C.	NULL
A.	NULL
Rosen	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
.	NULL

1992	NULL
.	NULL

IxB	NULL
interacts	NULL
with	NULL
the	NULL
nuclear	NULL
localization	NULL
sequences	NULL
of	NULL
the	NULL
subunits	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
a	NULL
mechanism	NULL
for	NULL
cytoplasmic	NULL
retention	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:1899-1913.	NULL
.	NULL

Berkhout	NULL
,	NULL
B.	NULL
,	NULL
A.	NULL
Gatignol	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Rabson	NULL
,	NULL
and	NULL
K.-T.	NULL
Jeang	NULL
.	NULL

1990	NULL
.	NULL

TAR	NULL
independent	NULL
activation	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
:	NULL
evidence	NULL
that	NULL
tat	NULL
requires	NULL
specific	NULL
regions	NULL
of	NULL
the	NULL
promoter	NULL
.	NULL

Cell	NULL
62:757-767.	NULL
.	NULL

Berra	NULL
,	NULL
E.	NULL
,	NULL
M.	NULL
T.	NULL
Diaz-Meco	NULL
,	NULL
I.	NULL
Dominguez	NULL
,	NULL
M.	NULL
M.	NULL
Municio	NULL
,	NULL
L.	NULL
Sanz	NULL
,	NULL
J.	NULL
Lozano	NULL
,	NULL
R.	NULL
S.	NULL
Chapkin	NULL
,	NULL
and	NULL
J.	NULL
Moscat	NULL
.	NULL

1993	NULL
.	NULL

Protein	NULL
kinase	NULL
C	NULL
zeta	NULL
isoform	NULL
is	NULL
critical	NULL
for	NULL
mitogenic	NULL
signal	NULL
transduction	NULL
.	NULL

Cell	NULL
74:555-563.	NULL
.	NULL

Brockman	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
D.	NULL
C.	NULL
Scherer	NULL
,	NULL
T.	NULL
A.	NULL
McKinsey	NULL
,	NULL
S.	NULL
M.	NULL
Hall	NULL
,	NULL
X.	NULL
Qi	NULL
,	NULL
W.	NULL
Y.	NULL
Lee	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Ballard	NULL
.	NULL

1995	NULL
.	NULL

Coupling	NULL
of	NULL
a	NULL
signal	NULL
response	NULL
domain	NULL
in	NULL
IxBa	NULL
to	NULL
multiple	NULL
pathways	NULL
for	NULL
NF-xB	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:2809-2818.	NULL
.	NULL

Brown	NULL
,	NULL
K.	NULL
,	NULL
S.	NULL
Gerstberger	NULL
,	NULL
L.	NULL
Carlson	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1995	NULL
.	NULL

Control	NULL
of	NULL
IxB-a	NULL
proteolysis	NULL
by	NULL
site-specific	NULL
,	NULL
signal-induced	NULL
phosphorylation	NULL
.	NULL

Science	NULL
267:1485-1488.	NULL
.	NULL

Devary	NULL
,	NULL
Y.	NULL
,	NULL
C.	NULL
Rosette	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
DiDonato	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1993	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
activa-	NULL
tion	NULL
by	NULL
ultraviolet	NULL
light	NULL
not	NULL
dependent	NULL
on	NULL
a	NULL
nuclear	NULL
signal	NULL
.	NULL

Science	NULL
261:1442-1445	NULL
.	NULL

Diaz-Meco	NULL
,	NULL
M.	NULL
T.	NULL
,	NULL
E.	NULL
Berra	NULL
,	NULL
M.	NULL
M.	NULL
Municio	NULL
,	NULL
L.	NULL
Sanz	NULL
,	NULL
J.	NULL
Lozano	NULL
,	NULL
I.	NULL
Dominguez	NULL
,	NULL
V.	NULL
Diaz-Golpe	NULL
,	NULL
M.	NULL
T.	NULL
Lain	NULL
de	NULL
Lera	NULL
,	NULL
J.	NULL
Alcami	NULL
,	NULL
C.	NULL
V.	NULL
Paya	NULL
,	NULL
F.	NULL
Arenzana-Seisdedos	NULL
,	NULL
J.-L.	NULL
Virelizier	NULL
,	NULL
and	NULL
J.	NULL
Moscat	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
dominant	NULL
negative	NULL
protein	NULL
kinase	NULL
C	NULL
{	NULL
subspecies	NULL
blocks	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:4770-4775	NULL
.	NULL

Diaz-Meco	NULL
,	NULL
M.	NULL
T.	NULL
,	NULL
I.	NULL
Dominguez	NULL
,	NULL
L.	NULL
Sanz	NULL
,	NULL
P.	NULL
Dent	NULL
,	NULL
J.	NULL
Lozano	NULL
,	NULL
M.	NULL
M.	NULL
Municio	NULL
,	NULL
E.	NULL
Berra	NULL
,	NULL
R.	NULL
T.	NULL
Hay	NULL
,	NULL
T.	NULL
W.	NULL
Sturgill	NULL
,	NULL
and	NULL
J.	NULL
Moscat	NULL
.	NULL

1994	NULL
.	NULL

{	NULL
PKC	NULL
induces	NULL
phosphorylation	NULL
and	NULL
inactivation	NULL
of	NULL
IxB-a	NULL
in	NULL
vitro	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:2842-2848	NULL
.	NULL

Diaz-Meco	NULL
,	NULL
M.	NULL
T.	NULL
,	NULL
J.	NULL
Lozano	NULL
,	NULL
M.	NULL
M.	NULL
Municio	NULL
,	NULL
E.	NULL
Berra	NULL
,	NULL
S.	NULL
Frutos	NULL
,	NULL
L.	NULL
Sanz	NULL
,	NULL
and	NULL
J.	NULL
Moscat	NULL
.	NULL

1994	NULL
.	NULL

Evidence	NULL
for	NULL
the	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
interaction	NULL
of	NULL
ras	NULL
with	NULL
protein	NULL
kinase	NULL
C	NULL
{	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:31706-31710	NULL
.	NULL

Dominguez	NULL
,	NULL
I.	NULL
,	NULL
M.	NULL
T.	NULL
Diaz-Meco	NULL
,	NULL
M.	NULL
M.	NULL
Municio	NULL
,	NULL
E.	NULL
Berra	NULL
,	NULL
A.	NULL
Garcia	NULL
de	NULL
Herreros	NULL
,	NULL
M.	NULL
E.	NULL
Cornet	NULL
,	NULL
L.	NULL
Sanz	NULL
,	NULL
and	NULL
J.	NULL
Moscat	NULL
.	NULL

1992	NULL
.	NULL

Evidence	NULL
for	NULL
a	NULL
role	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
{	NULL
subspecies	NULL
in	NULL
maturation	NULL
of	NULL
Xenopus	NULL
laevis	NULL
oocytes	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:3776-3783	NULL
.	NULL

Dominguez	NULL
,	NULL
I.	NULL
,	NULL
L.	NULL
Sanz	NULL
,	NULL
F.	NULL
Arenzana-Seisdedos	NULL
,	NULL
M.	NULL
'T	NULL
.	NULL

Diaz-Meco	NULL
,	NULL
JL	NULL
.	NULL

Virelizier	NULL
,	NULL
and	NULL
J.	NULL
Moscat	NULL
.	NULL

1993	NULL
.	NULL

Inhibition	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
£	NULL
subspecies	NULL
blocks	NULL
the	NULL
activation	NULL
of	NULL
an	NULL
NF-	NULL
«	NULL
B-like	NULL
activity	NULL
in	NULL
Xenopus	NULL
Ieevis	NULL
oocytes	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:1290-1295	NULL
.	NULL

Eicher	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
T.-H.	NULL
Tan	NULL
,	NULL
N.	NULL
R.	NULL
Rice	NULL
,	NULL
J.	NULL
J.	NULL
O'Shea	NULL
,	NULL
and	NULL
I.	NULL
C.	NULL
S.	NULL
Kennedy	NULL
.	NULL

1994	NULL
.	NULL

Expression	NULL
of	NULL
v-src	NULL
in	NULL
T	NULL
cells	NULL
correlates	NULL
with	NULL
nuclear	NULL
expression	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

152:2710-2718	NULL
.	NULL

Feuillard	NULL
,	NULL
J.	NULL
,	NULL
H.	NULL
Gouy	NULL
,	NULL
G.	NULL
Bismuth	NULL
,	NULL
L.	NULL
M.	NULL
Lee	NULL
,	NULL
P.	NULL
Debré	NULL
,	NULL
and	NULL
M.	NULL
Kirner	NULL
.	NULL

1991	NULL
.	NULL

NF-kB	NULL
activation	NULL
by	NULL
tumor	NULL
necrosis	NULL
factor	NULL
«	NULL
in	NULL
the	NULL
Jurkat	NULL
T	NULL
cell	NULL
line	NULL
is	NULL
independent	NULL
of	NULL
protein	NULL
kinase	NULL
A	NULL
,	NULL
protein	NULL
kinase	NULL
C	NULL
,	NULL
and	NULL
Ca	NULL
``	NULL
*-regulated	NULL
kinases	NULL
.	NULL

Cytokine	NULL
3:257-265	NULL
.	NULL

Finco	NULL
,	NULL
T.	NULL
S.	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1993	NULL
.	NULL

«	NULL
B	NULL
site-dependent	NULL
induction	NULL
of	NULL
gene	NULL
expression	NULL
by	NULL
diverse	NULL
inducers	NULL
of	NULL
nuclear	NULL
factor	NULL
xB	NULL
requires	NULL
raf-1	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:17676-17679	NULL
.	NULL

Ganchi	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
S.-C.	NULL
Sun	NULL
,	NULL
W.	NULL
C.	NULL
Greene	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Ballard	NULL
.	NULL

1992	NULL
.	NULL

I	NULL
«	NULL
B/	NULL
MAD-3	NULL
masks	NULL
the	NULL
nuclear	NULL
localization	NULL
signal	NULL
of	NULL
NF-xB	NULL
p65	NULL
and	NULL
requires	NULL
the	NULL
transactivation	NULL
domain	NULL
to	NULL
inhibit	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
DNA	NULL
binding	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Cell	NULL
3:1339-1352	NULL
.	NULL

Gartner	NULL
,	NULL
S.	NULL
,	NULL
P.	NULL
Karkovits	NULL
,	NULL
D.	NULL
M.	NULL
Markovitz	NULL
,	NULL
M.	NULL
H.	NULL
Kaplan	NULL
,	NULL
R.	NULL
C.	NULL
Gallo	NULL
,	NULL
and	NULL
M.	NULL
Popovic	NULL
.	NULL

1986	NULL
.	NULL

The	NULL
role	NULL
of	NULL
mononuclear	NULL
phagocytes	NULL
in	NULL
HTLV-II/LAV	NULL
infection	NULL
.	NULL

Science	NULL
233:215-219	NULL
.	NULL

Gendelman	NULL
,	NULL
H.	NULL
E.	NULL
,	NULL
J.	NULL
M.	NULL
Orenstein	NULL
,	NULL
L.	NULL
M.	NULL
Baca	NULL
,	NULL
B.	NULL
Weiser	NULL
,	NULL
H.	NULL
Burger	NULL
,	NULL
D.	NULL
C.	NULL
Kalter	NULL
,	NULL
and	NULL
M.	NULL
S.	NULL
Meltzer	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
macrophage	NULL
in	NULL
the	NULL
persistence	NULL
and	NULL
pathogenesis	NULL
of	NULL
HIV	NULL
infection	NULL
.	NULL

AIDS	NULL
3:475-495	NULL
.	NULL

Genot	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
P.	NULL
J.	NULL
Parker	NULL
,	NULL
and	NULL
D.	NULL
A.	NULL
Cantrell	NULL
.	NULL

1995	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
role	NULL
of	NULL
protein	NULL
kinase	NULL
C-a	NULL
,	NULL
-£	NULL
,	NULL
and	NULL
-f	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:9833-9839	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Activation	NULL
in	NULL
vitro	NULL
of	NULL
NF-kB	NULL
by	NULL
phosphorylation	NULL
of	NULL
its	NULL
inhibitor	NULL
IxB	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
344:678-682	NULL
.	NULL

Glineur	NULL
,	NULL
C.	NULL
,	NULL
M.	NULL
Bailly	NULL
,	NULL
and	NULL
J.	NULL
Ghysdael	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
c-Erb-A	NULL
a-encoded	NULL
thyroid	NULL
hormone	NULL
receptor	NULL
is	NULL
phosphorylated	NULL
in	NULL
its	NULL
amino	NULL
terminal	NULL
domain	NULL
by	NULL
casein	NULL
kinase	NULL
II	NULL
.	NULL

Oncogene	NULL
4:1247-1254	NULL
.	NULL

Han	NULL
,	NULL
J.	NULL
,	NULL
J.	NULL
D.	NULL
Lee	NULL
,	NULL
L.	NULL
Bibbs	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Ulevitch	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
MAP	NULL
kinase	NULL
targeted	NULL
by	NULL
endotoxin	NULL
and	NULL
hyperosmolarity	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Science	NULL
265:808-811.	NULL
.	NULL

Haskill	NULL
,	NULL
D.	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
Beg	NULL
,	NULL
S.	NULL
M.	NULL
Tompkins	NULL
,	NULL
J.	NULL
S.	NULL
Morris	NULL
,	NULL
A.	NULL
D.	NULL
Yurochko	NULL
,	NULL
A.	NULL
Sampson-Johannes	NULL
,	NULL
K.	NULL
Mondal	NULL
,	NULL
P.	NULL
Ralph	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1991	NULL
.	NULL

Characterization	NULL
of	NULL
an	NULL
immediate-carly	NULL
gene	NULL
induced	NULL
in	NULL
adherent	NULL
monocytes	NULL
that	NULL
encodes	NULL
IxB-like	NULL
activity	NULL
.	NULL

Cell	NULL
65:1281-1289	NULL
.	NULL

Herrero	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
P.	NULL
Mathew	NULL
,	NULL
and	NULL
C.	NULL
V.	NULL
Paya	NULL
.	NULL

1995	NULL
.	NULL

LMP-1	NULL
activates	NULL
NF-kB	NULL
by	NULL
targeting	NULL
the	NULL
inhibitory	NULL
molecule	NULL
IxBae	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:2168-2174	NULL
.	NULL

Jones	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
J.	NULL
T.	NULL
Kadonaga	NULL
,	NULL
P.	NULL
A.	NULL
Luciw	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1986	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
AIDS	NULL
retrovirus	NULL
promoter	NULL
by	NULL
the	NULL
cellular	NULL
transcription	NULL
factor	NULL
,	NULL
Sp1	NULL
.	NULL

Science	NULL
232:755-759.	NULL
voL	NULL
.	NULL

70	NULL
,	NULL
1996	NULL
28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

Kalebic	NULL
,	NULL
T.	NULL
,	NULL
A.	NULL
Kinter	NULL
,	NULL
G.	NULL
Poli	NULL
,	NULL
M.	NULL
E.	NULL
Anderson	NULL
,	NULL
A.	NULL
Meister	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Fauci	NULL
.	NULL

1991	NULL
.	NULL

Suppression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
expression	NULL
in	NULL
chronically	NULL
infected	NULL
monocytic	NULL
cells	NULL
by	NULL
glutathione	NULL
,	NULL
glutathione	NULL
ester	NULL
,	NULL
and	NULL
N-ace-tylcysteine	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:986-990	NULL
.	NULL

Laherty	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
H.	NULL
M.	NULL
Hu	NULL
,	NULL
A.	NULL
W.	NULL
Opipari	NULL
,	NULL
F.	NULL
Wang	NULL
,	NULL
and	NULL
V.	NULL
M.	NULL
Dixit	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
LMP1	NULL
gene	NULL
product	NULL
induces	NULL
A20	NULL
zinc	NULL
finger	NULL
protein	NULL
expression	NULL
by	NULL
activating	NULL
nuclear	NULL
factor	NULL
xB	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:24157-24160	NULL
.	NULL

Laurence	NULL
,	NULL
J.	NULL
,	NULL
S.	NULL
K.	NULL
Sikder	NULL
,	NULL
J.	NULL
Kulkosky	NULL
,	NULL
P.	NULL
Miller	NULL
,	NULL
and	NULL
P.	NULL
O.	NULL
P.	NULL
Ts	NULL
'	NULL
o	NULL
.	NULL

1991	NULL
.	NULL

Induction	NULL
of	NULL
chronic	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
infection	NULL
is	NULL
blocked	NULL
in	NULL
vitro	NULL
by	NULL
a	NULL
methylphosphonate	NULL
oligodeoxynucleoside	NULL
targeted	NULL
to	NULL
a	NULL
U3	NULL
enhancer	NULL
element	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:213-219	NULL
.	NULL

Leonard	NULL
,	NULL
J.	NULL
,	NULL
C.	NULL
Parrott	NULL
,	NULL
A.	NULL
J.	NULL
Buckler-White	NULL
,	NULL
E.	NULL
K.	NULL
Ross	NULL
,	NULL
M.	NULL
A.	NULL
Martin	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Rabson	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
long	NULL
terminal	NULL
repeat	NULL
are	NULL
not	NULL
required	NULL
for	NULL
virus	NULL
infectivity	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:4919-4924	NULL
.	NULL

Leung	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1988	NULL
.	NULL

HTLV-1	NULL
transactivator	NULL
induces	NULL
interleu-kin-2	NULL
receptor	NULL
expression	NULL
through	NULL
an	NULL
NF-	NULL
«	NULL
B-like	NULL
factor	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
333:776-778	NULL
.	NULL

Li	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Sedivy	NULL
.	NULL

1993	NULL
.	NULL

Raf-1	NULL
protein	NULL
kinase	NULL
activates	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
by	NULL
dissociating	NULL
the	NULL
cytoplasmic	NULL
NF-	NULL
«	NULL
B-IxB	NULL
complex	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:9247-9251	NULL
.	NULL

Limatola	NULL
,	NULL
C.	NULL
,	NULL
D.	NULL
Schaap	NULL
,	NULL
W.	NULL
H.	NULL
Mool	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
van	NULL
Blitterswijk	NULL
.	NULL

1994	NULL
.	NULL

Phosphatidic	NULL
acid	NULL
activation	NULL
of	NULL
protein	NULL
kinase	NULL
C-f	NULL
overexpressed	NULL
in	NULL
COS	NULL
cells	NULL
:	NULL
comparison	NULL
with	NULL
other	NULL
protein	NULL
kinase	NULL
C	NULL
isotypes	NULL
and	NULL
other	NULL
acidic	NULL
lipids	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

304:1001-1008	NULL
.	NULL

Liou	NULL
,	NULL
H.-C.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1993	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/rel	NULL
transcription	NULL
factor	NULL
and	NULL
IxB	NULL
inhibitor	NULL
system	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

5:477-487	NULL
.	NULL

Lozano	NULL
,	NULL
J.	NULL
,	NULL
E.	NULL
Berra	NULL
,	NULL
M.	NULL
M.	NULL
Municio	NULL
,	NULL
M.	NULL
T.	NULL
Diaz-Meco	NULL
,	NULL
I.	NULL
Dominguez	NULL
,	NULL
L.	NULL
Sanz	NULL
,	NULL
and	NULL
J.	NULL
Moscat	NULL
.	NULL

1994	NULL
.	NULL

Protein	NULL
kinase	NULL
C	NULL
{	NULL
isoform	NULL
is	NULL
critical	NULL
for	NULL
«	NULL
B-dependent	NULL
promoter	NULL
activation	NULL
by	NULL
sphingomyelinase	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
:	NULL
19200-19202	NULL
.	NULL

Lu	NULL
,	NULL
Y.	NULL
,	NULL
M.	NULL
Stenzel	NULL
,	NULL
J.	NULL
G.	NULL
Sodroski	NULL
,	NULL
and	NULL
W.	NULL
A.	NULL
Haseltine	NULL
.	NULL

1989	NULL
.	NULL

Effects	NULL
of	NULL
long	NULL
terminal	NULL
repeat	NULL
mutations	NULL
on	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
replication	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:4115-4119	NULL
.	NULL

McElhinny	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
W.	NULL
S.	NULL
MacMorran	NULL
,	NULL
G.	NULL
D.	NULL
Bren	NULL
,	NULL
R.	NULL
M.	NULL
Ten	NULL
,	NULL
A.	NULL
Israel	NULL
,	NULL
and	NULL
C.	NULL
V.	NULL
Paya	NULL
.	NULL

1995	NULL
.	NULL

Regulation	NULL
of	NULL
IxBa	NULL
and	NULL
p105	NULL
in	NULL
monocytes	NULL
and	NULL
macrophages	NULL
persistently	NULL
infected	NULL
with	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:1500-1509	NULL
.	NULL

Meichle	NULL
,	NULL
A.	NULL
,	NULL
S.	NULL
Schiitze	NULL
,	NULL
G.	NULL
Hensel	NULL
,	NULL
D.	NULL
Brunsing	NULL
,	NULL
and	NULL
M.	NULL
Krinke	NULL
.	NULL

1990	NULL
.	NULL

Protein	NULL
kinase	NULL
C-independent	NULL
activation	NULL
of	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
by	NULL
tumor	NULL
necrosis	NULL
factor	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265:8339-8343	NULL
.	NULL

Muller	NULL
,	NULL
G.	NULL
,	NULL
M.	NULL
Ayoub	NULL
,	NULL
P.	NULL
Storz	NULL
,	NULL
J.	NULL
Rennecke	NULL
,	NULL
D.	NULL
Fabbro	NULL
,	NULL
and	NULL
K.	NULL
Pfizenmaier	NULL
.	NULL

1995	NULL
.	NULL

PKC	NULL
{	NULL
is	NULL
a	NULL
molecular	NULL
switch	NULL
in	NULL
signal	NULL
transduction	NULL
of	NULL
TNF-	NULL
«	NULL
,	NULL
bifunc-tionally	NULL
regulated	NULL
by	NULL
ceramide	NULL
and	NULL
arachidonic	NULL
acid	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14:1961-1969	NULL
.	NULL

Nabel	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1987	NULL
.	NULL

An	NULL
inducible	NULL
transcription	NULL
factor	NULL
activates	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
326:711-713	NULL
.	NULL

Nakanishi	NULL
,	NULL
Y.	NULL
,	NULL
K.	NULL
A	NULL
.	NULL

Brewer	NULL
,	NULL
and	NULL
J.	NULL
H.	NULL
Exton	NULL
.	NULL

1993	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
zeta	NULL
isozyme	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
by	NULL
phosphatidylinositol	NULL
3,4,5-trisphosphate	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:13-16	NULL
.	NULL

Nishizuka	NULL
,	NULL
Y	NULL
.	NULL

1992	NULL
.	NULL

Intracellular	NULL
signaling	NULL
by	NULL
hydrolysis	NULL
of	NULL
phospholipids	NULL
and	NULL
activation	NULL
of	NULL
protein	NULL
kinase	NULL
C.	NULL
Science	NULL
258:607-614	NULL
.	NULL

Ohno	NULL
,	NULL
S.	NULL
,	NULL
H.	NULL
Kawasaki	NULL
,	NULL
S.	NULL
Imajoh	NULL
,	NULL
and	NULL
K.	NULL
Suzuki	NULL
.	NULL

1987	NULL
.	NULL

Tissue-specific	NULL
expression	NULL
of	NULL
three	NULL
distinct	NULL
types	NULL
of	NULL
rabbit	NULL
protein	NULL
kinase	NULL
C.	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
308:693-698	NULL
.	NULL

Parrott	NULL
,	NULL
C.	NULL
,	NULL
T.	NULL
Seidner	NULL
,	NULL
E.	NULL
Dub	NULL
,	NULL
J.	NULL
Leonard	NULL
,	NULL
T.	NULL
S.	NULL
Theodore	NULL
,	NULL
A.	NULL
Buckler-White	NULL
,	NULL
M.	NULL
A.	NULL
Martin	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Rabson	NULL
.	NULL

1991	NULL
.	NULL

Variable	NULL
role	NULL
of	NULL
the	NULL
long	NULL
PKC-f	NULL
MEDIATES	NULL
NF-	NULL
«	NULL
B	NULL
ACTIVATION	NULL
IN	NULL
MONOCYTES	NULL
46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

231	NULL
terminal	NULL
repeat	NULL
Sp1-binding	NULL
sites	NULL
in	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
replication	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:1414-1419	NULL
.	NULL

Paya	NULL
,	NULL
C.	NULL
V.	NULL
,	NULL
R.	NULL
M.	NULL
Ten	NULL
,	NULL
C.	NULL
Bessia	NULL
,	NULL
J.	NULL
Alcami	NULL
,	NULL
R.	NULL
T.	NULL
Hay	NULL
,	NULL
and	NULL
J.-L.	NULL
Virelizier	NULL
.	NULL

1992	NULL
.	NULL

NF-	NULL
«	NULL
B-dependent	NULL
induction	NULL
of	NULL
the	NULL
NF-xB	NULL
p50	NULL
subunit	NULL
gene	NULL
promoter	NULL
underlies	NULL
self-perpetuation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
transcription	NULL
in	NULL
monocytic	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:7826-7830	NULL
.	NULL

Perkins	NULL
,	NULL
N.	NULL
D.	NULL
,	NULL
N.	NULL
L.	NULL
Edwards	NULL
,	NULL
C.	NULL
S.	NULL
Duckett	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Agranoff	NULL
,	NULL
R.	NULL
M.	NULL
Schmid	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
cooperative	NULL
interaction	NULL
between	NULL
NF-kB	NULL
and	NULL
Sp1	NULL
is	NULL
required	NULL
for	NULL
HIV-1	NULL
enhancer	NULL
activation	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:3551-3558	NULL
.	NULL

Raziuddin	NULL
,	NULL
J.	NULL
,	NULL
A.	NULL
Mikovits	NULL
,	NULL
I.	NULL
Calvert	NULL
,	NULL
S.	NULL
Ghosh	NULL
,	NULL
H.-F.	NULL
Kung	NULL
,	NULL
and	NULL
F.	NULL
W.	NULL
Ruscetti	NULL
.	NULL

1991	NULL
.	NULL

Negative	NULL
regulation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
expression	NULL
in	NULL
monocytes	NULL
:	NULL
role	NULL
of	NULL
the	NULL
65-kDa	NULL
plus	NULL
50-kDa	NULL
NF-	NULL
«	NULL
B	NULL
dimer	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:9426-9430	NULL
.	NULL

Rodriguez-Viciana	NULL
,	NULL
P.	NULL
,	NULL
P.	NULL
H.	NULL
Warne	NULL
,	NULL
R.	NULL
Dhand	NULL
,	NULL
B.	NULL
Vanhaesebroeck	NULL
,	NULL
I.	NULL
Gout	NULL
,	NULL
M.	NULL
J.	NULL
Fry	NULL
,	NULL
M.	NULL
D.	NULL
Waterfield	NULL
,	NULL
and	NULL
J	NULL
.	NULL

Downward	NULL
.	NULL

1994	NULL
.	NULL

Phosphatidylinositol-3-OH	NULL
kinase	NULL
as	NULL
a	NULL
direct	NULL
target	NULL
of	NULL
ras	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
370:527-532	NULL
.	NULL

Roederer	NULL
,	NULL
M.	NULL
,	NULL
F.	NULL
J.	NULL
T.	NULL
Staal	NULL
,	NULL
P.	NULL
A.	NULL
Raju	NULL
,	NULL
S.	NULL
W.	NULL
Ela	NULL
,	NULL
L.	NULL
A.	NULL
Herzenberg	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
Herzenberg	NULL
,	NULL
.	NULL

1990	NULL
.	NULL

Cytokine-stimulated	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
replication	NULL
is	NULL
inhibited	NULL
by	NULL
N-acetyl-L-cysteine	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:4884-4888	NULL
.	NULL

Roulston	NULL
,	NULL
A.	NULL
,	NULL
P.	NULL
Beauparlant	NULL
,	NULL
N.	NULL
Rice	NULL
,	NULL
and	NULL
J.	NULL
Hiscott	NULL
.	NULL

1993	NULL
.	NULL

Chronic	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
infection	NULL
stimulates	NULL
distinct	NULL
NF-	NULL
«	NULL
B/re/	NULL
DNA	NULL
binding	NULL
activities	NULL
in	NULL
myelomonoblastic	NULL
cells	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:5235-5246	NULL
.	NULL

Selbie	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
C.	NULL
Schmitz-Peiffer	NULL
,	NULL
Y.	NULL
Sheng	NULL
,	NULL
and	NULL
T.	NULL
J.	NULL
Biden	NULL
.	NULL

1993	NULL
.	NULL

Molecular	NULL
cloning	NULL
and	NULL
characterization	NULL
of	NULL
PKCi	NULL
,	NULL
an	NULL
atypical	NULL
isoform	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
derived	NULL
from	NULL
insulin-secreting	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:24296-24302	NULL
.	NULL

Selby	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
B.	NULL
M.	NULL
Peterlin	NULL
.	NULL

1990	NULL
.	NULL

Trans-activation	NULL
by	NULL
HIV-1	NULL
tat	NULL
via	NULL
a	NULL
heterologous	NULL
RNA	NULL
binding	NULL
protein	NULL
.	NULL

Cell	NULL
62:769-776	NULL
.	NULL

Shirakawa	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
S.	NULL
B.	NULL
Mizel	NULL
.	NULL

1989	NULL
.	NULL

In	NULL
vitro	NULL
activation	NULL
and	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
catalyzed	NULL
by	NULL
cyclic	NULL
AMP-dependent	NULL
protein	NULL
kinase	NULL
and	NULL
protein	NULL
kinase	NULL
C.	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9:2424-2430	NULL
.	NULL

Sun	NULL
,	NULL
S.-C.	NULL
,	NULL
J.	NULL
Elwood	NULL
,	NULL
C.	NULL
Béraud	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1994	NULL
.	NULL

Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
tax	NULL
activation	NULL
of	NULL
NF-xB/rel	NULL
involves	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
of	NULL
IxBa	NULL
and	NULL
relA	NULL
(	NULL
p63	NULL
)	NULL
-mediated	NULL
induction	NULL
of	NULL
the	NULL
cel	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:7377-7384	NULL
.	NULL

Suzan	NULL
,	NULL
M.	NULL
,	NULL
D.	NULL
Salaun	NULL
,	NULL
C.	NULL
Neuveut	NULL
,	NULL
B.	NULL
Spire	NULL
,	NULL
I.	NULL
Hirsch	NULL
,	NULL
P.	NULL
Le	NULL
Bouteiller	NULL
,	NULL
G.	NULL
Querat	NULL
,	NULL
and	NULL
J.	NULL
Sire	NULL
.	NULL

1991	NULL
.	NULL

Induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
during	NULL
monocyte	NULL
differentiation	NULL
by	NULL
HIV	NULL
type	NULL
1	NULL
infection	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

146:377-383	NULL
.	NULL

Taylor	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
R.	NULL
J.	NULL
Pomerantz	NULL
,	NULL
G.	NULL
V.	NULL
Raj	NULL
,	NULL
F.	NULL
Kashanchi	NULL
,	NULL
J.	NULL
N.	NULL
Brady	NULL
,	NULL
S.	NULL
Amini	NULL
,	NULL
and	NULL
K.	NULL
Khalili	NULL
.	NULL

1994	NULL
.	NULL

Central	NULL
nervous	NULL
system-derived	NULL
cells	NULL
express	NULL
a	NULL
«	NULL
B-binding	NULL
activity	NULL
that	NULL
enhances	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
transcription	NULL
in	NULL
vitro	NULL
and	NULL
facilitates	NULL
TAR-independent	NULL
transactivation	NULL
by	NULL
Tat	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:3971-3981	NULL
.	NULL

Thompson	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
R.	NULL
J.	NULL
Phillips	NULL
,	NULL
H.	NULL
Erdjument-Bromage	NULL
,	NULL
P.	NULL
Tempst	NULL
,	NULL
and	NULL
S.	NULL
Ghosh	NULL
.	NULL

1995	NULL
.	NULL

IxBB	NULL
regulates	NULL
the	NULL
persistent	NULL
response	NULL
in	NULL
a	NULL
biphasic	NULL
activation	NULL
of	NULL
NF-kB	NULL
.	NULL

Cell	NULL
80:573-582	NULL
.	NULL

Toker	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
Meyer	NULL
,	NULL
K.	NULL
K.	NULL
Reddy	NULL
,	NULL
J.	NULL
R.	NULL
Falck	NULL
,	NULL
R.	NULL
Aneja	NULL
,	NULL
S.	NULL
Aneja	NULL
,	NULL
A.	NULL
Parra	NULL
,	NULL
D.	NULL
J.	NULL
Burns	NULL
,	NULL
L	NULL
,	NULL
M.	NULL
Ballas	NULL
,	NULL
and	NULL
L.	NULL
C.	NULL
Cantley	NULL
.	NULL

1994	NULL
.	NULL

Activation	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
family	NULL
members	NULL
by	NULL
the	NULL
novel	NULL
polyphosphoinositides	NULL
PidIns-3,4-P	NULL
;	NULL
and	NULL
PtdIns-3,4,5-P	NULL
,	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:32358-32367	NULL
.	NULL

Toullec	NULL
,	NULL
D.	NULL
,	NULL
P.	NULL
Pianetti	NULL
,	NULL
H.	NULL
Coste	NULL
,	NULL
P.	NULL
Bellevergue	NULL
,	NULL
T.	NULL
Grand-Perret	NULL
,	NULL
M.	NULL
Aja-kanes	NULL
,	NULL
V.	NULL
Baudet	NULL
,	NULL
P.	NULL
Boissin	NULL
,	NULL
E.	NULL
Boursier	NULL
,	NULL
F.	NULL
Loriolle	NULL
,	NULL
L.	NULL
Duhamel	NULL
,	NULL
D.	NULL
Charon	NULL
,	NULL
and	NULL
J.	NULL
Kirilovsky	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
bisindolylmaleimide	NULL
GF	NULL
109203X	NULL
is	NULL
a	NULL
potent	NULL
and	NULL
selective	NULL
inhibitor	NULL
of	NULL
protein	NULL
kinase	NULL
C.	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266:15771-15781	NULL
.	NULL

Ways	NULL
,	NULL
D.	NULL
K.	NULL
,	NULL
P.	NULL
P.	NULL
Cook	NULL
,	NULL
C.	NULL
Webster	NULL
,	NULL
and	NULL
P.	NULL
J.	NULL
Parker	NULL
.	NULL

1992	NULL
.	NULL

Effect	NULL
of	NULL
phorbol	NULL
esters	NULL
on	NULL
protein	NULL
kinase	NULL
C-	NULL
{	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:4799-4805	NULL
.	NULL

